| Section | Name | Details |
| 16.01 | Resource Thicken Up Clear® | |
| 06.01.01.02 | Insulin glargine 300units/ml Toujeo | Solution for injection (injection). Solostar, Doublestar |
| 20 | 5-Fluorouracil | 7.5mg in 0.3ml injection Approved by HaRD Area Prescribing Committee June 2014 |
| 05.03.01 | Abacavir Ziagen® | Commissioned by NHS England. All patients should routinely be started on Homecare |
| 05.03.01 | Abacavir and Lamivudine and Zidovudine Trizivir® | Commissioned by NHS England All patients should be routinely initiated on Homecare - not stocked at HDH |
| 10.01.03 | Abatacept Orencia® | Initiation by Consultant Rheumatologists only. |
| 24.16 | Abidec  Neonatal |
For all pre-term infants < 34 weeks gestation and/or <1500g birth weight. Dose: 0.6ml once daily (unlicensed dose) Commence when tolerated milk feed (formula or breast) ≥ 165ml/kg/day. Continue up to 6-12 months of age depending on diet. Dalivit® is available when there are supply problems with Abidec, however the dose is 0.3ml daily due to the higher vitamin A content. |
| 08.03.04.02 | Abiraterone Zytiga® | |
| 04.10 | Acamprosate Calcium Campral EC® | Tablets 333mg Initiation on the advice of a Psychiatrist |
| 11.06 | Acetazolamide Diamox® | Tablets 250mg MR capsules 250mg |
| 12.01.01 | Acetic acid solution | Solution 3%, 5% |
| 11.08.01 | Acetylcysteine 5% with Hypromellose 0.35% Ilube® | |
| 03.07 | Acetylcysteine effervescent tablets 600mg NACSYS | Prescribe by brand (NACSYS brand) NACSYS 600 mg effervescent tablets is indicated in adults only. |
| 18 | Acetylcysteine infusion Parvolex® | |
| 24.01 | Acetylcysteine injection  |
|
| 05.03.02.01 | Aciclovir | Tablets 200mg, 400mg, 800mg Infusion 250mg/10ml, 500mg/20ml (hospital only) |
| 11.03.03 | Aciclovir Zovirax® | Eye ointment 3% - Discontinued December 2018 - switch to ganciclovir |
| 24.01 | Aciclovir |
|
| 24.16 | Aciclovir Neonatal |
|
| 13.10.03 | Aciclovir 5% cream | |
| 13.05.02 | Acitretin Neotigason® | |
| 03.01.02 | Aclidinium bromide Eklira Genuair® | Licensed for COPD only |
| 01.05.03 | Adalimumab Humira® | Consultant request only Commissioned by NHS England for paediatric uveitis, juvenile arthritis and paediatric indications (where adult TA available) |
| 10.01.03 | Adalimumab Humira® | Initiation by Consultant Rheumatologists only |
| 13.05.03 | Adalimumab Humira® | Initiation by consultant Dermatologist only |
| 13.06.01 | Adapalene Differin® | |
| 13.06.01 | Adapalene & Benzoyl Peroxide Epiduo® | Approved by HaRD Area Prescribing Committee September 2013 |
| 02.03.02 | Adenosine Adenocor® | Injection 6mg/2ml |
| 24.01 | Adenosine |
|
| 24.01 | Adrenaline |
|
| 24.16 | Adrenaline Neonatal |
|
| 02.07.03 | Adrenaline / Epinephrine Adrenaline / Epinephrine 1 in 10000, dilute | |
| 03.04.03 | Adrenaline / Epinephrine Adrenaline / Epinephrine 1 in 1000 | Injection 1:1000 1mg/ml |
| 03.04.03 | Adrenaline / Epinephrine Adrenaline / Epinephrine 1 in 10000, dilute | Injection 1mg/10ml Pre-filled syringe 1mg/10ml |
| 03.04.03 | Adrenaline / Epinephrine Minijet® Adrenaline 1 in 10000 | Minijet 1mg/10ml |
| 03.04.03 | Adrenaline / Epinephrine Emerade® | 500 micrograms solution for injection in pre-filled pen |
| 03.04.03 | Adrenaline solution 500mcg/0.5ml PFP (Emerade) ® | Emerade pre-filled pen delivers a single dose of 0.5ml containing 500 micrograms of adrenaline (as tartrate). |
| 14.04 | Adsorbed Diphtheria [low dose], Tetanus and Inactivated Poliomyelitis Vaccine Revaxis® | |
| 14.04 | Adsorbed Diphtheria [low dose], Tetanus, Pertussis (Acellular, Component) and Inactivated Poliomyelitis Vaccine Repevax® | |
| 08.01.05 | Aflibercept Zaltrap® | NICE TA307: Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy |
| 11.08.02 | Aflibercept Eylea® | |
| 13.11.01 | Alcohol Industrial Methylated Spirit BP | |
| 08.02.03 | Alemtuzumab MabCampath® | Commissioned by NHS England for the treatment of multiple sclerosis, pre-transplant immunosupression and chronic lymphocytic luekemia (CLL) |
| 06.06.02 | Alendronic Acid | Tablets 70mg |
| 09.06.04 | Alfacalcidol | Capsules 0.25micrograms, 1microgram |
| 24.01 | Alfamino |
Paediatric Nutritional Products List - approved APC 05/18 |
| 15.01.04.03 | Alfentanil Rapifen® | |
| 17 | Alfentanil | Opiate of choice in severe renal impairment |
| 20.01 | Alirocumab Praluent® | First line in patients with LDL 3.5-4 (target LDL level 1.8) and in primary prevention (FH) with LDL > 5 |
| 02.05.05.03 | Aliskiren Rasilez® | Tablets 150mg For use by Renal Unit patients or on the advice of a specialist only |
| 13.05.01 | Alitretinoin Toctino® | Consultant Dermatologist recommendation only |
| 10.01.04 | Allopurinol | Tablets 100mg, 300mg |
| 02.14 | Alprostadil Prostin VR® | Injection 500microgram/ml For use in neonates only |
| 07.04.05 | Alprostadil Caverject® | |
| 07.04.05 | Alprostadil MUSE® | |
| 07.04.05 | Alprostadil Vitaros® | Approved by the HaRD Area Prescribing Committee, February 2015. To be prescribed on the recommendation of a Consultant Urologist ONLY. |
| 24.16 | Alprostadil Neonatal |
500microgram/ml injection |
| 02.10.02 | Alteplase Actilyse® | Injection 20mg, 50mg For specialist use only |
| 24.01 | Althera |
|
| 13.12 | Aluminimum Salts Anhydrol Forte® | |
| 09.05.02.02 | Aluminium Hydroxide Alu-Cap® | Capsules 475mg Initiation on the advice of a Renal Specialist |
| 01.02 | Alverine Citrate Spasmonal® | |
| 04.09.01 | Amantadine Hydrochloride Symmetrel® | |
| 05.01.04 | Amikacin | |
| 02.02.03 | Amiloride Hydrochloride | |
| 03.01.03 | Aminophylline | Injection 250mg/10ml Phyllocontin MR tablets 100mg, 225mg Prescribe by brand for different MR formulations of theophylline and aminophylline to avoid confusion between them. |
| 24.01 | Aminophylline |
|
| 24.01 | Amiodarone |
|
| 02.03.02 | Amiodarone Hydrochloride | Tablets 100mg 200mg; Injection 150mg/3ml; Minijet 300mg/10ml |
| 04.02.01 | Amisulpride | Tablets 50mg, 200mg Liquid 500mg/5ml |
| 04.07.03 | Amitriptlyine | Tablets 10mg, 25mg, 50mg Liquid 50mg/5ml |
| 04.03.01 | Amitriptyline Hydrochloride | Tablets 10mg, 25mg, 50mg Liquid 50mg/5ml |
| 02.06.02 | Amlodipine | Tablets 5mg, 10mg |
| 05.01.01.03 | Amoxicillin | Capsules 250mg & 500mg Syrup 125mg/5ml & 250mg/5ml Injection 250mg, 500mg and 1g powder (hospital only) |
| 24.01 | Amoxicillin |
|
| 24.16 | Amoxicillin Neonatal |
|
| 11.99.99.99 | Amphotericin | |
| 09.01.04 | Anagrelide Xagrid® | Capsules 500micrograms Initiation by Consultant Haematologists only |
| 08.03.04.01 | Anastrozole Arimidex® | Tablets 1mg |
| 15.02 | Antacid with Oxetacaine | |
| 14.05.03 | Anti-D (Rh0) Immunoglobulin Rhophylac® | |
| 02.08.02 | Apixaban Eliquis® | See NICE guidance. |
| A5.03.03 | Aquacel Ag ribbon | In secondary care, wards to order from Pharmacy for each individual patient. |
| 13.02.01 | Aqueous Cream BP ZeroAQS® | 100g, 500g |
| 13.09 | Arachis (peanut) oil Extract of Coal Tar 0.3%, Cade Oil 0.3%, Coal Tar Solution 0.1%, Oleyl Alcohol 1% and Tar 0.3% Polytar® |
|
| 02.08.01 | Argatroban Exembol® | |
| 04.02.01 | Aripiprazole Abilify® | Tablets 5mg, 10mg, 15mg - Not Stocked Initiation by Consultant Psychiatrists only, requested through LPG on an individual patient basis. |
| 04.02.02 | Aripiprazole Abilify | |
| 05.04.01 | Artemether with lumefantrine Riamet® | On the advice of the Infectious Diseases Team at Leeds |
| 12.03.05 | AS saliva Orthana® | Product is of animal origin (procine) so therefore not suitable for all patient groups. |
| 09.06.03 | Ascorbic Acid | Tablets 50mg, 200mg, 500mg |
| 04.07.01 | Aspirin | Soluble tablets 300mg |
| 02.09 | Aspirin (antiplatelet) Aspirin® | Dispersible tablets 75mg Not to be used as monotherapy for atrial fibrilation |
| 02.04 | Atenolol | Tablets 25mg, 50mg, 100mg; Liquid 25mg/5ml; Injection 5mg/10ml |
| 04.04 | Atomoxetine Strattera® | Capsules 10mg Initiation on the advice of a specialist |
| 02.12 | Atorvastatin Lipitor® | Tablets 10mg, 20mg, 40mg, 80mg |
| 07.01.03 | Atosiban Tractocile® | Injection 7.5mg/ml (5ml) Concentrate for infusion 7.5mg/ml (0.9ml) |
| 24.16 | Atracurium Neonatal |
|
| 15.01.05 | Atracurium Besilate | |
| 24.16 | Atropine Neonatal |
|
| 11.05 | Atropine Sulphate | Eye drops 1% Eye ointment 1% |
| 15.01.03 | Atropine Sulphate | |
| 08.01.03 | Azacitidine Vidaza® | |
| 08.02.01 | Azathioprine | Tablets 25mg, 50mg |
| 10.01.03 | Azathioprine | Tablets 25mg, 50mg |
| 13.05.03 | Azathioprine | Tablets 25mg, 50mg This is to be used with the shared care guidelines - see link. * Note this is for an UNLICENSED indication* |
| 13.06.01 | Azelaic Acid Finacae® | |
| 12.02.01 | Azelastine Hydrochloride Rhinolast® | Aqueous nasal spray 140micrograms/metered spray |
| 05.01.05 | Azithromycin | Long term use of Azithromycin in non – cystic bronchiectasis is an ‘off-label’ use for azithromycin. To be initiated by the specialist Respiratory Team only. |
| 05.01.02.03 | Aztreonam Azactam® | Injection 1g powder |
| 10.02.02 | Baclofen | Tablets 10mg Liquid 5mg/5ml |
| 01.05.01 | Balsalazide Sodium Colazide® | Capsules 750mg |
| 10.01.03 | Baricitinib Olumiant | |
| 13.02.02 | Barrier preparation Conotrane® | 100g |
| 13.02.02 | Barrier preparation Sudocrem® | |
| 13.02.02 | Barrier preparation Metanium® | Ointment 30g |
| 13.02.02 | Barrier preparation Siopel® | 50g |
| 24.16 | BCG vaccination Neonatal |
|
| 14.04 | BCG vaccine diagnostic agent Tuberculline Purified Protein Derivative (PPD) | |
| 14.04 | BCG vaccine Intradermal Bacillus Calmette-Guerin Vaccine | |
| 03.02 | Beclometasone Dipropionate Beclazone Easi-Breathe® | 100 micrograms/dose, 250 micrograms/dose |
| 03.02 | Beclometasone Dipropionate Clenil Modulite® | 50 micrograms/dose, 100 micrograms/dose, 200 micrograms/dose, 250 micrograms/dose Prescribe by brand. Clenil Modulite is not interchangeable with other CFC-free inhalers. |
| 03.02 | Beclometasone Dipropionate Qvar® | 100 micrograms/dose Easi-breathe inhaler Prescribe by brand. Qvar is not interchangeable with other CFC-free inhalers. |
| 12.02.01 | Beclometasone Dipropionate Beconase / Nasobec | Aqueous nasal spray 50micrograms/spray |
| 24.01 | Beclometasone inhaler |
|
| 03.01 | Beclometasone, Formoterol and Glycopyrronium Trimbow® | Each metered dose (the dose leaving the valve) contains 100 micrograms of beclometasone dipropionate, 6 micrograms of formoterol fumarate dihydrate and 10 micrograms of glycopyrronium (as 12.5 micrograms glycopyrronium bromide). |
| 03.02 | Beclometasone/formoterol Fostair® | Aerosol inhaler (licensed for both asthma and COPD) NEXThaler® (licensed for asthma only) Beclomethasone 100 micrograms/ formoterol 6 micrograms Equivalent to Seretide 125 and Symbicort 200/6. For initiation by respiratory specialists only. |
| 03.01 | benralizumab Fasenra | Added as TA565 available Patients are referred to Leeds or Hull for this treatment.
|
| 20 | BENZBROMARONE Tablets 100 mg, 50mg | For patients intolerant to allopurinol and febuxostat only. |
| 03.08 | Benzoin Tincture Compound BP Friar's Balsam | |
| 13.06.01 | Benzoyl Peroxide PanOxyl® | Gel 2.5%, 10% |
| 13.06.01 | Benzoyl Peroxide 5% with Clindamycin 1% Duac® Once Daily | |
| 12.03.01 | Benzydamine Difflam | Oral rinse Spray |
| 24.01 | Benzydamine oral spray |
|
| 05.01.01.01 | Benzylpenicillin | Injection 600mg & 1.2g powder |
| 24.01 | Benzylpenicillin |
|
| 24.16 | Benzylpenicillin Neonatal |
|
| 04.06 | Betahistine Dihydrochloride | Tablets 8mg |
| 11.04.01 | Betamethasone | Eye drops 0.1% Eye ointment 0.1% |
| 13.04 | Betamethasone (as Dipropionate) 0.05% with Salicylic Acid 3% Diprosalic® | Potent |
| 13.04 | Betamethasone (as Valerate) 0.025% Betnovate-RD® | Moderate |
| 13.04 | Betamethasone (as Valerate) 0.1% Betnovate® | Potent |
| 13.04 | Betamethasone (as Valerate) 0.1% with Clioquinol Betnovate-C® | Potent |
| 13.04 | Betamethasone (as Valerate) 0.1% with Fucidic Acid 2% Fucibet® | Potent |
| 11.04.01 | Betamethasone 0.1% with Neomycin 0.5% | Eye drops Eye ointment Temporarily discontinued |
| 12.01.01 | Betamethasone Sodium Phosphate | Ear/Ear/Nose drops 0.1% |
| 12.02.01 | Betamethasone Sodium Phosphate 0.1% | Eye/Ear/Nose drops |
| 12.01.01 | Betamethasone Sodium Phosphate 0.1% with Neomycin Sulphate 0.5% | Eye/Ear/Nose drops (betamethasone 0.1%/ neomycin 0.5%) |
| 13.04 | Betamethasone Valerate 2.25mg medicated plaster Betesil® | Inflammatory skin disorders Approved APC November 2019 |
| 11.06 | Betaxolol Hydrochloride Betoptic® | Eye drops 0.5% |
| 08.01.05 | Bevacizumab Avastin® | |
| 11.08.02 | Bevacizumab Avastin® | Intravitreal injection 1.25mg (Unlicensed) Initiation by Consultant Ophthalmologist only |
| 08.03.04.02 | Bicalutamide Casodex® | |
| 11.06 | Bimatoprost Lumigan® | Eye drops 300micrograms/ml This is been discontinued and unlikely to be available after August 2015 |
| 11.06 | Bimatoprost preservative-free Lumigan UD ® | For patients with hypersensitivity to preservatives Approved by HaRD APC May 2013 |
| 11.06 | Bimatoprost with Timolol Ganfort® | Eye drops (Bimatoprost 300micrograms/ml & timolol 0.5%) Use only if patients are non-compliant with the two individual eye drops |
| 12.03.05 | BioXtra® | |
| 06.01.01.02 | Biphasic Insulin Aspart NovoMix® 30 | Cartridge Flexpen |
| 06.01.01.02 | Biphasic Insulin Lispro Humalog® Mix25 | Cartridge Kwikpen |
| 06.01.01.02 | Biphasic Insulin Lispro Humalog® Mix50 | Cartridge Kwikpen |
| 06.01.01.02 | Biphasic Isophane Insulin Humulin® M3 | Cartridge Kwikpen |
| 01.06.02 | Bisacodyl | Suppositories 5mg, 10mg First choice in primary care |
| 02.04 | Bisoprolol Fumarate | Tablets 1.25mg, 2.5mg, 5mg First line in heart failure |
| 09.05.01.02 | Bisphosphonates | |
| 08.01.02 | Bleomycin | |
| 24.16 | Blood Products Neonatal |
|
| 04.09.03 | Botulinum Toxin Type A Botox® | Injection 100units On the advice of a specialist. Prescribe by brand |
| 04.09.03 | Botulinum Toxin Type A Dysport® | Injection 500units Initiation on the advice of a specialist. Prescribe by brand |
| 04.09.03 | Botulinum Toxin Type B NeuroBloc® | |
| 01.06.05 | Bowel Cleansing Solutions Moviprep® | Approved by HaRD Area Prescribing Committee September 2013. |
| 01.06.05 | Bowel Cleansing Solutions Picolax® | |
| 13.06 | Brimonidine 0.3% Gel Mirvaso® | Brimonidine gel will not be effective in inflammatory rosacea i.e. it will not treat papules and pustules. Do not treat erythema associated with rosacea unless the inflammatory component is controlled. If the inflammatory component of rosacea is difficult to manage please refer to secondary care - do not treat with Brimonidine. Brimonidine will not be effective in a proportion of patients. The onset on action is less than an hour in most patients. HDFT Dermatologists practice is to give a test dose, and assess the patient at 1-2 hours. If Brimonidine treatment is judged to be effective by the clinician, it can be prescribed. The patient should be informed that increasing the topical dose to more than the five pea sized applications to the face once daily will NOT improve efficacy and is an off-licence use. Patients should be informed that the product can be used once daily, but it is acceptable to use on a PRN basis. Rebound erythema can occur 5-10 hours post dose which seems to be responsive to further application of Brimonidine (off licence use). Further studies are required to elucidate if this rebound is associated with any long term adverse events. |
| 11.06 | Brinzolamide Azopt® | Eye drops 10mg/ml |
| 11.06 | Brinzolamide 1% with Timolol 0.5% (Azarga®) | Eye drops (Brinzolamide 10mg & timolol 0.5%) For use only if patients are non-compliant with the two individual eye drops |
| 11.06 | Brinzolamide 10mg/ml & Brimonidine 2mg/ml Eye Drops Simbrinza® | Approved by the Area Prescribing Committee, December 2014. |
| 04.08.01 | Brivaracetam Briviact® | Initiation on the advice of a Neurologist |
| 13.05.02 | Brodalumab | |
| 01.05.02 | Budesonide Budenofalk® | MR Capsules 3mg |
| 03.02 | Budesonide | Pulmicort® Easyhaler® |
| 03.01 | Budesonide and Formoterol Fobumix® | Each delivered dose (the dose that leaves the mouthpiece) contains: budesonide 160 micrograms/inhalation and formoterol fumarate dihydrate 4.5 micrograms/inhalation. |
| 03.02 | Budesonide and formoterol Symbicort® | Turbohaler budesonide 200micrograms/formoterol 6 micrograms per dose For initiation by repiratory specialists only |
| 24.01 | Budesonide nebules |
|
| 02.02.02 | Bumetanide | |
| 15.02 | Bupivacaine and Adrenaline | |
| 15.02 | Bupivacaine Hydrochloride | |
| 15.02 | Bupivacaine hydrochloride Marcain heavy® | |
| 04.07.02 | Buprenorphine BuTrans® | Patches 5micrograms/hr, 10micrograms/hr, Butec is preferred brand in primary care |
| 04.07.02 | Buprenorphine Temgesic® | Sublingual tablets 0.4mg, 2mg |
| 04.07.02 | Buprenorphine Transtec® | Patches 35micrograms/hr, 52.5micrograms/hr, 70micrograms/hr Change every 96 hours Initiation on the advice of a specialist |
| 04.10 | Buprenorphine Subutex® | Not stocked at HDFT Initiation on the advice of a Consultant Psychiatrist |
| 02.02.04 | Burinex A® | Tablets amiloride/bumetanide 5/1mg |
| 08.01.01 | Busulfan Myleran® | |
| 03.04.03 | C1 Esterase Inhibitor Berinert® | |
| 04.09.01 | Cabergoline | Tablets 500micrograms Initiation on the advice of a specialist |
| 06.07.01 | Cabergoline Dostinex® | Tablets 500micrograms Initiation on the advice of a specialist |
| 24.16 | Caffeine citrate Neonatal |
|
| 13.03 | Calamine | Lotion 200ml |
| 13.05.02 | Calcipotriol Dovonex® | |
| 13.05.02 | Calcipotriol 50micrograms/g with Betamethasone 0.05% Dovobet® gel and ointment and Enstilar® cutaneous foam | When prescribing Dovobet Gel, please prescribe "Dovobet Gel with Applicator". This aids administration to the scalp. Please note that NICE states that Dovobet is a 4th line topical in patients with mild psoriasis that are able to adhere to twice daily treatment. Topical treatment of psoriasis affecting the trunk and limbs 1.3.2.1 Offer a potent corticosteroid applied once daily plus vitamin D or a vitamin D analogue applied once daily (applied separately, one in the morning and the other in the evening) for up to 4 weeks as initial treatment for adults with trunk or limb psoriasis. 1.3.2.2 If once-daily application of a potent corticosteroid plus once-daily application of vitamin D or a vitamin D analogue does not result in clearance, near clearance or satisfactory control of trunk or limb psoriasis in adults after a maximum of 8 weeks[22], offer vitamin D or a vitamin D analogue alone applied twice daily. 1.3.2.3 If twice-daily application of vitamin D or a vitamin D analogue does not result in clearance, near clearance or satisfactory control of trunk or limb psoriasis in adults after 8–12 weeks[22], offer either: a potent corticosteroid applied twice daily for up to 4 weeks or a coal tar preparation applied once or twice daily. 1.3.2.4 If a twice-daily potent corticosteroid or coal tar preparation cannot be used or a once-daily preparation would improve adherence in adults offer a combined product containing calcipotriol monohydrate and betamethasone dipropionate applied once daily for up to 4 weeks. |
| 06.06.01 | Calcitonin (salmon) / Salcatonin Miacalic® | Injection 100 units/ml Initiation on the advice of a specialist |
| 13.05.02 | Calcitriol 3micrograms/g Silkis® | |
| 08.01 | Calcium Folinate | Injection 50mg/5ml |
| 24.16 | Calcium gluconate Neonatal |
|
| 09.05.01 | Calcium Gluconate 10% | Please see link to Hypocalcaemia Guidelines |
| 09.05.01.01 | Calcium Salts Calcium Chloride | |
| 09.05.02.02 | Calcium Salts Calcichew® | Chewable tablets 1.25mg (500mg calcium) Initiation on the advice of a Renal Specialist |
| 09.05.02.02 | Calcium Salts Phosex® | Tablets 1g Initiation on the advice of a Renal Specialist |
| 06.01.02.03 | Canagliflozin Invokana® | Approved by the Area Prescribing Committee September 2014 |
| 02.05.05.02 | Candesartan Cilexetil Amias® | Tablets 4mg 8mg 16mg |
| 20 | Cantharadin, podophyllin and salicylic acid Cantherone Plus® | Approved by HaRD Area Prescribing Committee April 2014 for an initial 3 month trial. To be initiated by Consultant Dermatologists only and used if all other treament options have failed. |
| 08.01.03 | Capecitabine Xeloda® | |
| 04.07.03 | Capsacin | Cream 0.025%, 0.075% For initiation by a specialist |
| 10.03.02 | Capsaicin Zacin® | Cream 0.025%, 0.075% For use by specialist pain team only |
| 24.01 | Captopril liquid |
Licensed liquid available |
| 04.07.03 | Carbamazepine | Tablets 100mg, 200mg Liquid 100mg/5ml |
| 04.08.01 | Carbamazepine | Tablets 100mg, 200mg MR tablets 200mg, 400mg Liquid 100mg/5ml Suppositories 125mg, 250mg Prescribe by brand |
| 24.01 | Carbamazepine |
|
| 06.02.02 | Carbimazole Neo-Mercazole® | Tablets 5mg, 20mg |
| 03.07 | Carbocisteine | Capsules 375mg Liquid 250mg/5ml Stop after a 4 week trial if no benefit |
| 11.08.01 | Carbomer 980 0.2% Clinitas® | If thicker viscousity required |
| 07.01.01 | Carboprost Hemabate® | Injection 250micrograms/ml |
| 11.08.01 | Carmellose 1% Celluvisc® | If thicker viscosity required (preservative-free) |
| 11.08.01 | Carmellose Sodium 0.5% Evolve® | First line if preservative-free option required |
| 08.01.01 | Carmustine BiCNU® | |
| 24.16 | Carobel Neonatal |
|
| 02.04 | Carvedilol | Tablets 3.125mg, 6.25mg, 12.5mg For Consultant use only Second line in heart failure |
| 07.04.04 | Catheter Patency Solutions Chlorhexidine 0.02% | |
| 07.04.04 | Catheter Patency Solutions Sodium Chloride 0.9% | |
| 07.04.04 | Catheter Patency Solutions Solution G | |
| 05.01.02.01 | Cefaclor | Liquid 250mg/5ml |
| 05.01.02.01 | Cefalexin | Capsules 250mg & 500mg Liquid 250mg/5ml |
| 24.01 | Cefalexin |
|
| 05.01.02.01 | Cefixime Suprax® | Tablets 200mg Liquid 100mg/5ml |
| 05.01.02.01 | Cefotaxime | Injection 500mg & 1g powder Formulary Indication: Meningitis For all other indications microbiology advice should be sought |
| 24.01 | CefoTAXime |
|
| 24.16 | Cefotaxime Neonatal |
|
| 05.01.02.01 | Ceftazidime | Injection 1g & 2g powder For use on microbiology advice ONLY Ceftazidime-Avibactam (Zaficefta) also approved for use on microbiology advice ONLY |
| 24.16 | Ceftazidime Neonatal |
|
| 05.01.02.01 | Ceftriaxone | Injection 1g Powder Paediatrics ONLY, unless recommended by a consultant microbiologist. |
| 24.01 | CefTRIAXone |
|
| 05.01.02.01 | Cefuroxime | Injection 250mg, 750mg & 1.5g powder |
| 11.03.01 | Cefuroxime | Intracameral injection 3mg |
| 24.01 | CefUROXime |
|
| 24.16 | Cefuroxime Neonatal |
|
| 10.01.01 | Celecoxib Celebrex® | Capsules 100mg Initiation on the advice of a Consultant Rheumatologist only |
| 10.01.03 | Certolizumab Pegol Cimzia® | Initiation by a Consultant Rheumatologist |
| 03.04.01 | Cetirizine | First-line at HDFT Tablets 10mg; Liquid 5mg/5ml |
| 24.01 | Cetirizine |
|
| 08.01.05 | Cetuximab Erbitux® | |
| 04.09.01 | changed to amberApomorphine Hydrochloride APO-go® | Injection 20mg/2ml, 50mg/5ml |
| 04.01.01 | Chloral Hydrate | Liquid 500mg/5ml Unlicensed |
| 24.01 | Chloral hydrate |
|
| 20 | CHLORAL HYDRATE mixture 1g/10ml | |
| 08.01.01 | Chlorambucil Leukeran® | Tablets 2mg |
| 05.01.07 | Chloramphenicol | Eye drops (0.5%) & ointment (1%) Injection 1g Topical use for conjuctivitis |
| 11.03.01 | Chloramphenicol | Eye drops 0.5% Eye ointment 1% Minims 0.5% |
| 24.16 | Chloramphenicol Neonatal |
|
| 04.01.02 | Chlordiazepoxide Hydrochloride | For alcohol detoxification only |
| 13.11.02 | Chlorhexidine Gluconate 0.5% (Aqueous) | |
| 13.11.02 | Chlorhexidine Gluconate 0.015% with Cetrimide 0.15% Tisept® | |
| 13.11.02 | Chlorhexidine Gluconate 4% | Brands include Hydrex |
| 13.11.02 | Chlorhexidine Gluconate Solution 2.5% (≡ Chlorhexidine Gluconate 0.5%) (Alcoholic) | |
| 13.11.02 | Chlorhexidine Gluconate Solution 5% (≡ Chlorhexidine Gluconate 1%) Hibitane Obstetric® | |
| 12.02.03 | Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% Naseptin® | Nasal cream Contains peanut oil |
| 12.03.02 | Chlorhexidine Mouthwash | Mouthwash 0.2% Mint flavour |
| 24.16 | Chlorothiazide Neonatal |
|
| 24.01 | Chlorphenamine |
|
| 03.04.01 | Chlorphenamine Maleate | Tablets 4mg; Liquid 2mg/5ml; Injection 10mg/ml |
| 04.02.01 | Chlorpromazine Hydrochloride | Tablets 10mg, 25mg, 50mg, 100mg Injection 50mg/2ml (hospital only) Liquid 100mg/5ml |
| 02.02.01 | Chlortalidone | |
| 12.03.01 | Choline Salicylate Bonjela® Adult | |
| 08.02.02 | Ciclosporin | Due to differences in bioavailability, patients must remain on the same brand of immunosuppressant except on the advice of specialist clinician. MUST be prescribed by brand. |
| 10.01.03 | Ciclosporin | Capsules 25mg, 50mg, 100mg Due to differences in bioavailability, patients must remain on the same brand of immunosuppressant except on the advice of specialist clinician. MUST be prescribed by brand. |
| 13.05.03 | Ciclosporin | Due to differences in bioavailability, patients must remain on the same brand of immunosuppressant except on the advice of specialist clinician. MUST be prescribed by brand. |
| 11.03 | Ciclosporin 0.1% eye drops Verkazia® | Atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC) in children over 4 years |
| 11.08.01 | Ciclosporin 1mg/mL Eye Drops Ikervis® | Approved in line with NICE TA369 |
| 09.05.01.02 | Cinacalcet Mimpara® | Tablets 30mg, 90mg For use by the Renal Unit only |
| 05.01.12 | Ciprofloxacin | Tablets 250mg Infusion 200mg/100ml & 400mg/200ml (hospital only) Approved Indications: Complicated UTIs Pyelonephritis (2nd Line) Urinary Sepsis (2nd Line) Severe Salmonella/Campylobacter Severe Otitis Externa Prostatitis Human/Animal Bites Micobiology advice should be sought for all other indications |
| 12.01.01 | Ciprofloxacin 3mg/ml fluocinolone acetonide 0.25mg/ml Cetraxal Plus® | Approved by HaRD Area Prescribing Committee March 2019 |
| 08.01.05 | Cisplatin | |
| 04.03.03 | Citalopram | Tablets 10mg, 20mg Oral drops 40mg/ml (8 oral drops = 10mg tablet) |
| 01.06.05 | Citrafleet® | |
| 20 | Citric acid 0.6mol/5ml | Approved by HaRD APC for the assessment of laryngeal sensation via Cough Reflex Testing (CRT) in patients admitted with stroke with a known or suspected swallowing impairment |
| 08.01.03 | Cladribine Litak® | |
| 08.01.03 | Cladribine | |
| 05.01.05 | Clarithromycin | Tablets 250mg Liquid 125mg/5ml Injection 500mg powder (hospital only) |
| 24.01 | Clarithromycin |
|
| 24.16 | Clarithromycin Neonatal |
|
| 05.01.06 | Clindamycin | Capsules 150mg Liquid 75mg/5ml (Unlicensed) Injection 300mg/2ml |
| 24.01 | Clindamycin |
Suspension is unlicensed |
| 13.06.01 | Clindamycin 1% Dalacin T® | |
| 04.08.01 | Clobazam | Tablets 10mg Initiation on the advice of a Neurologist |
| 13.04 | Clobetasol Propionate 0.05% Dermovate® | Cream 30g, 100g
Very potent |
| 13.04 | Clobetasone Butyrate 0.05% Eumovate® | Cream 30g
Moderate |
| 13.04 | Clobetasone Butyrate 0.05%, Oxytetracycline 3%, Nystatin 100,000 units/g Trimovate® | Moderate |
| 06.05.01 | Clomifene Citrate Clomid® | Tablets 50mg |
| 04.08.01 | Clonazepam Rivotril® | Tablets 500micrograms Initiation on the advice of a Neurologist |
| 04.08.02 | Clonazepam Rivotril® | Injection 1mg/ml |
| 24.01 | Clonidine (growth hormone stimulation test) |
|
| 02.09 | Clopidogrel | Tablets 75mg |
| 04.09.03 | Clostridium Botulinum neurotoxin type A Xeomin® | To be used in line with NICE TA 605 - see link Initiation on the advice of a specialist. Prescribe by brand |
| 07.02.02 | Clotrimazole | Cream 1% Solution 1% Pessaries 200mg, 500mg |
| 12.01.01 | Clotrimazole Canesten® | Cream 1% |
| 13.10.02 | Clotrimazole | Cream and Solution |
| 04.02.01 | Clozapine Clozaril® | Tablets 25mg, 100mg Initiation by specialists only. Patients must be registered with Clozaril monitoring service. |
| 13.05.02 | Coal Tar 10% Carbo-Dome® | |
| 13.05.02 | Coal Tar in Lassars Paste | |
| 13.05.02 | Coal Tar Solution 12%, Salicylic Acid 2%, Precipitated Sulphur 4% Sebco® | |
| 13.05.02 | Coal Tar Solution 2.5%, Arachis (peanut) Oil extract of Coal Tar 7.5%, Tar 7.5%, Cade Oil 7.5%, Liqiud Paraffin 35% Polytar Emollient® | |
| 02.02.04 | Co-amilofruse (furosemide and amiloride) | Tablets amiloride/furosemide 2.5/20mg, 5/40mg |
| 05.01.01.03 | Co-Amoxiclav | Tablets 375mg & 625mg Syrup 125/31mg & 250/62mg Injection 1.2g powder Should be prescribed as "Amoxicillin/Clavulanate" to identify it as a penicillin. Indications Animal/Human Bites Open fractures |
| 24.01 | Co-amoxiclav |
|
| 24.16 | Co-amoxiclav Neonatal |
|
| 04.09.01 | Co-Beneldopa Madopar®CR | |
| 04.09.01 | Co-Beneldopa Madopar® | Benserazide/levodopa Capsules 12.5/50, 25/100, 50/200 Dispersible tablets 12.5/50, 25/100 MR capsules 25/100 |
| 15.02 | Cocaine | |
| 04.09.01 | Co-Careldopa Sinemet® CR | |
| 04.09.01 | Co-Careldopa Sinemet® | Carbidopa/levodopa Tablets 10/100, 12.5/50, 25/100, 25/250 MR tablets 25/100, 50/200 |
| 04.09.01 | Co-Careldopa Half Sinemet ®CR | |
| 04.09.01 | Co-Careldopa and Entacapone Sastravi® | |
| 13.06.02 | Co-Cyprindiol 2000/35 (Cyproterone Acetate 2mg with Ethinylestradiol 35micrograms) Dianette® |
|
| 01.06.02 | Co-danthramer | Suspension 25/200 in 5ml; Strong suspension 75/1000 in 5ml For palliative patients only |
| 01.06.02 | Co-danthrusate | Capsules 50/60 |
| 03.09.01 | Codeine Linctus BP | Liquid 15mg/5ml |
| 01.04.02 | Codeine Phosphate | Tablets 15mg 30mg |
| 04.07.02 | Codeine Phosphate | Tablets 15mg, 30mg Liquid 15mg/5ml Injection 60mg/ml - CONTROLLED DRUG |
| 04.07.02 | Codeine Phosphate Codeine Linctuses | Liquid 15mg/5ml |
| 10.01.04 | Colchicine | Tablets 500 micrograms |
| 24.16 | Colecalciferol Neonatal |
3000units/ml oral solution (unlicensed) |
| 09.06.04 | Colecalciferol (vitamin D3) | |
| 09.06.04 | Colecalciferol and Calcium Carbonate Adcal-D3® | |
| 02.12 | Colesevelam Cholestagel® | management of bile acid malabsorption |
| 01.09.02 | Colestyramine | Sachets 4g |
| 05.01.07 | Colistin Colomycin® | Approved by the Area Prescribing Committee for non-cystic fibrosis bronchiectasis |
| 10.03.01 | Collagenase clostridium histolyticum Xiapex® | |
| 01.01.01 | Co-magaldrox Maalox® | |
| 07.03.01 | Combined Hormonal Contraceptives Millinette20/75® | Ethinylestradiol 20micrograms/gestodene 75 micrograms Approved by HaRD Area Prescribing Committee June 2014 |
| 07.03.01 | Combined Hormonal Contraceptives Mercilon/Gedarel 20/150® | Tablets ethinyestradiol 20micrograms/ desogestrel 150micrograms |
| 07.03.01 | Combined Hormonal Contraceptives Evra® | Patch ethinylestradiol 33.9micrograms/24hours & norelgestromin 203micrograms/24hours |
| 07.03.01 | Combined Hormonal Contraceptives Logynon® | Tablets |
| 07.03.01 | Combined Hormonal Contraceptives Microgynon 30® Rigevidon ® Levest® | Tablets Ethinylestradiol 30micrograms/ levonorgestrel 150micrograms |
| 07.03.01 | Combined Hormonal Contraceptives Cilest® | Tablets ethinylestradiol 35micrograms, norgestimate 250micrograms |
| 07.03.01 | Combined Hormonal Contraceptives Marvelon/Gedarel 30/150® | Tablets ethinylestradiol 30micrograms/ desogestrel 150micrograms |
| 07.03.01 | Combined Hormonal Contraceptives Yasmin® Lucette ® | Tablets Ethinylestradiol 30micrograms/ drospirenone 3mg |
| 07.03.01 | Combined Hormonal Contraceptives Femodene® | Tablets Ethinylestradiol 30micrograms / gestodene 75micrograms |
| 06.01.06 | Contour Black Edition meter | |
| 01.04.02 | Co-Phenotrope Lomotil® | Tablets |
| 05.01.08 | Co-trimoxazole | (Trimethoprim/sulfamethoxazole) Tablets 480mg & 960mg Injection 480mg/5ml |
| 13.03 | Crotamiton Eurax/Eurax HC® | Cream 10% (30g) With hydrocortisone 2.5% (30g) |
| 04.06 | Cyclizine | Tablets 50mg Injection 50mg/ml |
| 17 | Cyclizine | Dose: 50mg s/c every 8 hours prn |
| 24.16 | Cyclopentolate 0.5% eye drops Neonatal |
|
| 11.05 | Cyclopentolate Hydrochloride | Eye drops 0.5%, 1% |
| 11.05 | Cyclopentolate Hydrochloride single use Minims® Cyclopentolate Hydrochloride | Eye drops 1% |
| 08.01.01 | Cyclophosphamide | Tablets 50mg |
| 06.04.02 | Cyproterone Acetate | Tablets 100mg Initiation on the advice of a specialist |
| 08.03.04.02 | Cyproterone Acetate | Tablets 100mg |
| 08.01.03 | Cytarabine | |
| 02.08.02 | Dabigatran Pradaxa® | See NICE guidance. |
| 08.01.05 | Dabrafenib Tafinlar® | Patients are referred to Leeds Teaching Hospitals |
| 06.07.02 | Danazol | Capsules 100mg, 200mg Initiation on the advice of a specialist |
| 10.02.02 | Dantrolene Sodium Dantrium® | Capsules 25mg, 100mg Injection 20mg |
| 15.01.08 | Dantrolene Sodium Dantrium Intravenous® | |
| 06.01.02.03 | Dapagliflozin Forxiga® | |
| 05.01.07 | Daptomycin Cubicin® | For use on microbiology advice ONLY |
| 08.01.05 | Dasatinib Sprycel® | |
| 08.01.02 | Daunorubicin | |
| 09.01.03 | Deferasirox Exjade® | Dispersible tablets 125mg, 250mg, 500mg Initiation by Consultant Haematologist only |
| 09.01.03 | Deferiprone Ferriprox® | Tablets 500mg Initiation by Consultant Haematologist only |
| 08.03.04.02 | Degarelix Firmagon® | Approved by the Area Prescribing Committee, December 2014 |
| 06.06.02 | Denosumab Prolia® | Initiation in accordance with shared care guidelines |
| 09.01.03 | Desferrioxamine Mesilate Desferal® | Injection 500mg |
| 15.01.02 | Desflurane Suprane® | |
| 06.05.02 | Desmopressin | Tablets 200micrograms (Desmotabs) Nasal spray 10 micrograms/dose (Desmospray) Sublingual tablets 120 micrograms(Desmomelt) Intravenous injection 4 micrograms/mL Subcutanous injection 15 micrograms/mL (Octim) Initiation on the advice of a specialist |
| 24.01 | Desmopressin |
|
| 06.03.02 | Dexamethasone | Tablets 500micrograms, 2mg Injection 3.3mg base(4mg/ml as sodium phosphate) Injection 6.6mg base (8mg/2ml as sodium phosphate) |
| 11.04.01 | Dexamethasone Maxidex® | Eye drops 0.1% |
| 11.04.01 | Dexamethasone Minims® Dexamethasone | Eye drops 0.1% |
| 11.04.02 | Dexamethasone Ozurdex® | Intra-vitreal implant 700micrograms |
| 24.01 | Dexamethasone |
|
| 24.16 | Dexamethasone Neonatal |
|
| 12.01.01 | Dexamethasone with Antibacterial Otomize® | Ear spray (dexamethasone 0.1%, neomycin 3250 units/ml, glacial acetic acid 2%) |
| 11.04.01 | Dexamethasone with Neomycin and Polymyxin B sulphate maxitrol® | Eye drops |
| 04.04 | dexamfetamine | |
| 17 | Diamorphine | First choice opiate in normal renal function |
| 24.01 | Diamorphine |
|
| 04.07.02 | Diamorphine Hydrochloride | Injection 5mg, 10mg, 30mg, 100mg Intranasal spray (Ayendi®) |
| 04.01.02 | Diazepam | Tablets 2mg, 5mg, 10mg Liquid 2mg/5ml |
| 04.08.02 | Diazepam | Rectal solution 5mg/2.5ml, 10mg/2.5ml Injection 10mg/2ml Emulsion injection 10mg/2ml |
| 04.08.03 | Diazepam | Rectal solution 5mg/2.5ml, 10mg/2.5ml Injection 10mg/2ml (hospital only) |
| 10.02.02 | Diazepam | Tablets 2mg, 5mg, 10mg Liquid 2mg/5ml |
| 24.01 | Diazepam |
|
| 10.01.01 | Diclofenac Sodium | Tablets EC 25mg, 50mg MR tablets 75mg, 100mg Dispersible tablets 50mg Suppositories 12.5mg, 50mg, 100mg Gel 1% |
| 10.01.01 | Diclofenac Sodium Voltarol® | Injection 75mg/3ml |
| 13.08.01 | Diclofenac Sodium Solaraze® | Second line |
| 08.03.01 | Diethylstilbestrol | |
| 24.01 | Diethylstilboestrol (pre-pubertal priming) |
See individual protocols for clonidine and glucagon stimulation tests |
| 02.01.01 | Digibind | |
| 02.01.01 | Digoxin | |
| 04.07.02 | Dihydrocodeine Tartrate | Tablets 30mg Liquid 10mg/5ml Injection 50mg/ml - CONTROLLED DRUG |
| 01.07.04 | Diltiazem Cream 2% | Unlicensed |
| 02.06.02 | Diltiazem Hydrochloride Tildiem® | MR tablets (SR) 60mg, 90mg, 120mg (twice daily dosing) MR capsules (LA) 200mg, 300mg (once daily dosing) Prescribe by brand |
| 02.06.02 | Diltiazem Hydrochloride Adizem® | SR Capsules 90mg, 120mg, 180mg (twice daily dosing) XL Capsules 120mg, 180mg, 240mg, 300mg (once daily dosing) Prescribe by brand |
| 02.06.02 | Diltiazem Hydrochloride Adizem-SR® | MR Capsules 90mg, 120mg, 180mg Prescribe by brand |
| 02.06.02 | Diltiazem Hydrochloride Dilzem® SR | MR Capsules (SR) 60mg (twice daily dosing) Prescribe by brand |
| 13.05.02 | Dimethyl Fumarate Skilarence® | |
| 20 | DIMETHYL SULPHOXIDE Bladder Instillation 50% | |
| 13.10.04 | Dimeticone Hedrin® | |
| 07.01.01 | Dinoprostone Prostin E2® | Vaginal gel 1mg/2.5ml, 2mg/2.5ml Extra-amniotic solution 5mg/0.5ml |
| 07.01.01 | Dinoprostone Propess® | Pessaries 10mg |
| 11.01 | Diphoterine® eye wash solution | use in chemical attacks and serious eye/face chemical burns |
| 14.04 | Diphtheria, Tetanus, Pertussis (Acellular, Component), Poliomyelitis (Inactivated) and Haemophilus Type b Conjugate Vaccine (Adsorbed), Hepatitis B (Infanrix Hexa®) | |
| 24.16 | Diphtheria, Tetanus, Pertussis (Acellular, Component), Poliomyelitis (Inactivated) and Haemophilus Type b Conjugate Vaccine (Adsorbed), Hepatitis B (Infanrix Hexa®) Neonatal |
|
| 02.09 | Dipyridamole Persantin® Retard | MR capsules 200mg |
| 02.09 | Dipyridamole and Aspirin Asasantin® Retard | MR capsules aspirin/dipyridamole 25/200mg |
| 06.06.02 | Disodium Pamidronate | Injection 30mg |
| 02.03.02 | Disopyramide | MR Tablets 250mg; Capsules 100mg; Injection 50mg/5ml (hospital only) |
| 04.10 | Disulfiram Antabuse® | Tablets 200mg Initiation on the advice of a Psychiatrist |
| 13.05.02 | Dithranol Dithrocream® | |
| 20 | DITHRANOL 0.1% /0.25%,0.5%,1%,2%,4%in lassars paste | |
| 02.07.01 | Dobutamine | Injection 250mg/20ml |
| 24.01 | Dobutamine |
|
| 24.16 | Dobutamine Neonatal |
|
| 04.06 | Domperidone | Tablets 30mg Domperidone is no longer licensed for those weighing less than 35 kg |
| 04.11 | Donepezil Hydrochloride Aricept® | Tablets 5mg, 10mg |
| 24.01 | Dopamine |
|
| 24.16 | Dopamine Neonatal |
|
| 02.07.01 | Dopamine Hydrochloride | Injection 200mg/5ml, 800mg/20ml |
| 03.07 | Dornase Alfa Pulmozyme® | Nebuliser solution 2.5mg/2.5ml |
| 11.06 | Dorzolomide Trusopt® | Eye drops 2% |
| 11.06 | Dorzolomide 2% with Timolol 0.5% Cosopt® | Eye drops (Dorzolamide 2% & timolol 0.5%) |
| 15.01.07 | Doxapram Hydrochloride Dopram® | |
| 02.05.04 | Doxazosin | Tablets 1mg, 2mg, 4mg |
| 13.04 | Doxepin Hydrochloride Xepin® | |
| 08.01.02 | Doxorubicin Hydrochloride | |
| 05.01.03 | Doxycycline | Capsules 100mg Dispersible tablets 100mg |
| 12.03.01 | Doxycycline | |
| 12.03.02 | Doxycycline | Dispersible tablets 100mg (unlicensed indication) Use as a mouthwash (third line option after chlorhexidine mouthwash and betamethasone soluble tablets used as a mouthwash) |
| 02.03.02 | Dronedarone Multaq® | For use by Cardiology Specialists only if intolerant to amiodarone |
| 04.06 | Droperidol Xomolix® | Injection 2.5mg/ml On the advice of a specialist |
| 03.01.05 | Drug Delivery Device Haleraid® | 120 dose, 200 dose |
| 03.01.05 | Drug Delivery Device Volumatic® | Standard Standard with mask |
| 03.01.05 | Drug Delivery Device AeroChamber® | Child with mask (yellow) Infant with mask (orange) Standard (blue) Standard with mask (blue) |
| 06.01.02.03 | Dulaglutide Trulicity® | Approved by the Area Prescribing Committee (July 2015) in line with NICE criteria. Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber). |
| 04.03.04 | Duloxetine Cymbalta® | Capsules 30mg, 60mg Only on the advice of a specialist. Specify brand |
| 24.01 | Duocal Super Soluble Powder | Paediatric Nutritional Products List - approved APC 05/18 |
| 13.05.03 | Dupilumab Dupixent® | For use by Consultant Dermatologists only - for the treatment of moderate-to-severe atopic dermatitis in adult patients who are candidates for systemic therapy. |
| 02.08.02 | Edoxaban Lixiana® | Dabigatran and edoxaban will be reserved for those who have a contra-indication to, or intolerant of rivaroxaban / apixaban or where the prescriber feels dabigatran or edoxaban would be the most appropriate agent. |
| 10.02.01 | Edrophonium Chloride | Injection 10mg/ml |
| 15.01.06 | Edrophonium Chloride | |
| 13.09 | Eflornithine Vaniqa® | For Dermatology and Endocrinology |
| 24.01 | Elemental 028 Extra Liquid | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Elemental 028 Extra Powder | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.16 | Elfin Trial Neonatal |
|
| 09.01.04 | Eltrombopag Revolade® | Approved in line with NICE TA293 |
| 13.02.01 | Emollient Imuderm® | |
| 13.02.01.01 | Emollient Bath Additive Zerolatum® | |
| 13.02.01 | Emollient preparation zerocream® | 50g |
| 13.02.01 | Emollient preparation Cetraben® | |
| 13.02.01 | Emollient preparation Zerobase® | Tube 50g
|
| 13.02.01 | Emollient preparation Zeroderm® | Ointment 500g |
| 13.02.01 | Emollient preparation containing Urea 10% Flexitol® | Flexitol or cheapest equivalent |
| 13.02.01 | Emollient preparation containing Urea 5% Imuderm® | |
| 13.02.01 | Emollient preparation with antimicrobials Dermol 500® | Lotion 500ml Use under specialist advice only. Linked to Wound Dressing Guideline 05/18 |
| 06.01.02.03 | Empagliflozin Jardiance® | Approved by the HaRD Area Prescribing Committee, April 2015, in line with NICE TA336 |
| 02.08.01 | Enoxaparin Sodium 100mg in 1mL and 150mg in 1mL | Pre-filled syringe 20mg, 40mg, 60mg, 80mg, 100mg, 120mg, 150mg For therapeutic dosing when CrCl is <30ml/min |
| 04.09.01 | Entacapone Comtess® | Tablets 200mg |
| 08.03.04.02 | Enzalutamide Xtandi® | |
| 12.02.02 | Ephedrine Hydrochloride | Nose drops 0.5% |
| 02.07.02 | Ephedrine Hydrocloride | Injection 30mg/ml; Pre-filled syringe 30mg/10ml |
| 08.01.02 | Epirubicin hydrochloride | |
| 02.02.03 | Eplerenone Inspra® | Initiation by Cardiology specialists only. Patients to be switched to spironolactone 25mg daily by GP after 28 days of treatment with eplerenone. |
| 09.01.03 | Epoetin alfa Eprex® | |
| 02.09 | Eptifibatide Integrilin® | Injection 20mg/10ml Infusion 75mg/100ml |
| 09.06.04 | Ergocalciferol | Injection 300,000 units |
| 07.01.01 | Ergometrine Maleate Ergometrine | Injection 500micrograms/ml |
| 07.01.01 | Ergometrine Maleate and Oxytocin Syntometrine® | Injection ergometrine 500micrograms & oxytocin 5units/ml |
| 08.01.05 | Erlotinib Tarceva® | |
| 05.01.02.02 | Ertapenem Invanz® | Microbiology advice only |
| 06.01.02.03 | Ertugliflozin Steglatro® | |
| 05.01.05 | Erythromycin | Tablets 250mg |
| 24.01 | Erythromycin |
|
| 24.16 | Erythromycin Neonatal |
|
| 13.06.01 | Erythromycin 40mg with Zinc Acetate 12mg/mL Zineryt® | |
| 02.04 | Esmolol Hydrochloride Brevibloc® | Injection 10mg/ml |
| 10.01.03 | Etanercept Enbrel® | Initiation by Consultant Rheumatologists only |
| 10.01.03 | Etanercept Benepali | Initiated by consultant rheumatologist or dermatologist only. |
| 13.05.03 | Etanercept Benapali® | Initiation by a consultant Dermatologist only |
| 13.05.03 | Etanercept Enbrel ® | Initiation by consultant Dermatologist only |
| 06.06.01 | Etelcalcetide Parsabiv | |
| 05.01.09 | Ethambutol Hydrochloride Ethambutol® | |
| 02.13 | Ethanolamine Oleate | Injection 5% |
| 04.08.01 | Ethosuximide | On specialist recommendation only in line with NICE guidance |
| 15.02 | Ethyl Chloride Cryogesic® Spray | |
| 15.01.01 | Etomidate Hypnomidate® | |
| 08.01.04 | Etoposide | |
| 10.01.01 | Etoricoxib Arcoxia® | Tablets 30mg, 60mg, 90mg Initiation on the advice of a Consultant Rheumatologist only |
| 20.01 | Evolocumab Repatha® | Secondary prevention high risk/ v high risk with LDL above 4 and in primary prevention (FH) with LDL > 5 |
| 08.03.04.01 | Exemestane Aromasin® | Tablets 25mg |
| 06.01.02.03 | Exenatide Byetta® | Pre-filled pen 5-micrograms/dose, 10micrograms/dose Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber). |
| 06.01.02.03 | Exenatide Prolonged Release Bydureon® | Injection 2mg Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber). For use in patients with compliance problems with daily injections. |
| 02.12 | Ezetimibe Ezetrol® | Tablets 10mg |
| 10.01.04 | Febuxostat Adenuric® | Tablets 80mg |
| 02.12 | Fenofibrate | Tablets 160mg |
| 04.07.02 | Fentanyl | Patches 12micrograms/hr, 25micrograms/hr, 50micrograms/hr, 75micrograms/hr, 100micrograms/hr Mezolar is the preferred brand patch in primary care. Injection 100micrograms/2ml, 500micograms/10ml Hodspital only). Nasal spray (PecFent) approved as a Green Drug for patients who have failed all other options. |
| 15.01.04.03 | Fentanyl | |
| 24.01 | Fentanyl |
|
| 24.16 | Fentanyl Neonatal |
10microgram/ml injection (unlicensed) |
| 09.01.01.01 | Ferrous Fumarate Fersaday® | Tablets 322mg (100mg iron) Formulary switch from ferrous sulphate |
| 05.01.07 | Fidaxomicin DIFICLIR® | Approved for use after recommendation from Microbiology |
| 09.01.06 | Filgrastim Zarzio® | Pre-filled syringe 300 micrograms/0.5ml 480 micrograms/0.5ml |
| 06.04.02 | Finasteride Proscar® | Tablets 5mg |
| A5.03.04 | Flaminal Forte Gel | On specialist advice only. Wards to order from Pharmacy for each individual patient. |
| A5.03.04 | Flaminal Hydro Gel | On specialist advice only. Wards to order from Pharmacy for each individual patient. |
| 02.03.02 | Flecainide Acetate | Tablets 100mg; Injection 150mg/5ml (hospital only) |
| 13.04 | Flucinolone Acetonide 0.0025% Synalar 1 in 10 Dilution® | |
| 13.04 | Flucinolone Acetonide 0.00625% Synalar 1 in 4 Dilution® | |
| 13.04 | Flucinolone Acetonide 0.025% Synalar® | |
| 05.01.01.02 | Flucloxacillin | Capsules 250mg & 500mg Syrup 125mg/ml & 250mg/5ml Injection 500mg & 1g powder |
| 24.01 | Flucloxacillin |
|
| 24.16 | Flucloxacillin Neonatal |
|
| 07.02.02 | Fluconazole | Capsules 50mg Suspension 50mg/5ml |
| 24.01 | Fluconazole |
|
| 24.16 | Fluconazole Neonatal |
|
| 08.01.03 | Fludarabine Phosphate Fludara® | |
| 06.03.01 | Fludrocortisone Acetate Florinef® | Tablets 100micrograms |
| 13.04 | Fludroxycortide Haelan® | |
| 24.01 | Fluids intravenous |
|
| 24.16 | Fluids intravenous Neonatal |
|
| 15.01.07 | Flumazenil | |
| 24.16 | Flumazenil Neonatal |
|
| 12.01.01 | Flumetasone Pivalate 0.02% with Clioquinol 1% Locorten-Vioform® | |
| 12.01.01 | Flumetasone Pivalate 0.02% with Clioquinol 1% Locorten-Vioform® | Ear drops |
| 11.04.01 | Fluocinolone acetonide Iluvien ® | Intravitreal implant |
| 11.08.02 | Fluorescein Sodium Minims® | Minims 2% |
| 11.04.01 | Fluorometholone FML® | Eye drops Fluorometholone 0.1% & Polyvinyl alcohol 1.4% |
| 08.01.03 | Fluorouracil | |
| 13.08.01 | Fluorouracil Efudix® | |
| 04.03.03 | Fluoxetine | Capsules 20mg Liquid 20mg/5ml |
| 04.02.02 | Flupentixol Decanoate Depixol® | Injection 12.5mg/0.5ml, 20mg/ml, 25mg/ml, 40mg/2ml, 50mg/0.5ml, 100mg/ml |
| 04.02.02 | Fluphenazine Decanoate | Injection 50mg/0.5ml, 100mg/ml |
| 08.03.04.02 | Flutamide | |
| 03.02 | Fluticasone and formeterol Flutiform | Metered dose inhaler |
| 03.02 | Fluticasone and salmeterol Sirdupla® | Accuhaler (dry powder inhaler) -fluticasone 100 micrograms/salmeterol -fluticasone 250 micrograms/salmeterol -fluticasone 500 micrograms/salmeterol Evohaler (metered dose inhaler) -fluticasone 50 micrograms/salmeterol -fluticasone 125 micrograms/salmeterol -fluticasone 250 micrograms/salmeterol Please note that the Seretide brand of inhalers are only approved for use in children. |
| 12.02.01 | Fluticasone furoate Avamys® | Nasal spray 27.5micrograms/metered spray Initiation by ENT and Respiratory Consultants only. |
| 03.01 | fluticasone furoate, umeclidinium bromide and vilanterol Trelegy Ellipta ® | Each single inhalation provides a delivered dose (the dose leaving the mouthpiece) of 92 micrograms fluticasone furoate, 65 micrograms umeclidinium bromide equivalent to 55 micrograms umeclidinium and 22 micrograms vilanterol (as trifenatate). |
| 12.02.01 | Fluticasone Propionate Flixonase/Nasofan® | Aqueous nasal spray 50micrograms/metered spray |
| 03.02 | Fluticasone/Vilanterol Relvar Ellipta® | Relvar Ellipta 92 micrograms/22 micrograms inhalation powder |
| 03.02 | Fluticasone/Vilanterol Relvar Ellipta® | Relvar Ellipta 184 micrograms/22 micrograms inhalation powder |
| 09.01.02 | Folic Acid | Tablets 5mg Liquid 2.5mg/5ml |
| 24.16 | Folic acid Neonatal |
2.5mg/5ml liquid |
| 02.08.01 | Fondaparinux Sodium Arixtra® | Pre-filled syringe 5mg/ml For use in acute coronary syndromes |
| 24.01 | Forceval Junior | Approved by APC 05/18 for use by prescribers following: GUIDELINES FOR THE IN-PATIENT MANAGEMENT OF PAEDIATRIC PATIENTS WITH EATING DISORDERS (UNDER 16 YEARS) See link |
| 03.01.04 | Formoterol / aclidinium Duaklir® Genuair | Licensed for COPD only |
| 03.01.01.01 | Formoterol Fumarate Easyhaler® | 12 micrograms/metered inhalation |
| 24.01 | Fortini | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Fortini Compact Multifibre | Paediatric Nutritional Products List - approved APC 05/18 |
| 04.06 | Fosaprepitant Ivemend® | Injection 150mg Prescribed on the advice of a specialist only pre-chemotherapy |
| 20 | Fosfomycin 2g Injection Fomicyt® | Approved by the HaRD Area Prescribing Committee, April 2015. To be prescribed on the advice of Microbiology only. |
| 20 | FOSFOMYCIN Sachets 3 g | Initiation on the advice of a Microbiologist |
| 06.01.06 | FreeStyle Optium Neo Meter | |
| 02.11 | Fresh Frozen Plasma | Available from Haematology |
| 08.03.04.01 | Fulvestrant Faslodex® | Injection 50mg/ml |
| 02.02.02 | Furosemide | Long-term supply problem with furosemide 500mg - switch to bumetanide |
| 24.01 | Furosemide |
|
| 24.16 | Furosemide Neonatal |
|
| 11.03.01 | Fusidic Acid Fucithalmic® | Eye drops MR 1% |
| 13.10.01.02 | Fusidic Acid 2% Fucidin® | |
| 04.07.03 | Gabapentin | Capsules 100mg, 300mg, 400mg Liquid 250mg/5ml - reserve for patients with long-term swallowing difficulty or long-term feeding tubes. |
| 04.08.01 | Gabapentin | Capsules 100mg, 300mg, 400mg |
| 04.11 | Galantamine Reminyl® XL | MR capsules 8mg, 16mg, 24mg Initiation on the advice of a specialist for patients intolerant to donepezil. MR formulation for patients non-compliant with standard release formulation. |
| 04.11 | Galantamine | Tablets 12mg Liquid 4mg/ml Initiation on the advice of a specialist for patients intolerant to donepezil |
| 11.03.03 | Ganciclovir 0.15% Virgan® | |
| 20.02 | Gastrografin gastroenteral solution | For the radiological examination of the gastrointestinal tract. Approved APC May 2020 |
| 01.01.02 | Gaviscon Infant | Sachets |
| 08.01.05 | Gefitinib Iressa® | |
| 08.01.03 | Gemcitabine Gemzar® | |
| 07.01.01 | Gemeprost | Pessary 1mg For miscarriage if mifepristone & misoprostol have failed. Discuss with Consultant in Obs&Gynae before prescribing. |
| 05.01.04 | Gentamicin | Injection 20mg/2ml & 80mg/2ml |
| 11.03.01 | Gentamicin | Eye drops 0.3% |
| 24.01 | Gentamicin |
|
| 24.16 | Gentamicin Neonatal |
|
| 12.01.01 | Gentamicin 0.3% with Hydrocortisone Acetate 1% Gentisone® HC | |
| 01.07.01 | Germaloids® | Cream; Ointment; Suppositories |
| 12.03.05 | Glandosane® | Aerosol spray |
| 06.01.02.01 | Glibenclamide | Tablets 2.5mg, 5mg Initiation on the advice of a specialist |
| 06.01.02.01 | Gliclazide | Tablets 80mg MR tablets 30mg - Initiation on the advice of a specialist. NB: Gliclazide and gliclazide MR doses are not bioequivalent. Contact a diabetes specialist for advice |
| 06.01.02.01 | Glimepiride | Tablets 1mg Initiation on the advice of a specialist |
| 06.01.04 | Glucagon GlucaGen® HypoKit | Injection 1mg |
| 24.01 | Glucagon |
|
| 06.01.04 | Glucojuice Glucojuice | Approved by the Area Prescribing Committee March 2017 |
| 06.01.06 | GlucoMen LX beta-ketone | |
| 06.01.06 | GlucoMen LX Plus meter | |
| 06.01.06 | GlucoRx HCT & Ketone meter | |
| 06.01.06 | GlucoRx Nexus meter | |
| 06.01.04 | Glucose | Tablets Injection 50% |
| 06.01.04 | Glucose gel Glucogel | Oral gel 40% (3x25g) |
| 09.02.02.01 | Glucose Intravenous | 5% (100ml, 250ml, 500ml, 1000ml)) 10% (500ml) 12.5% (250ml) 15% (500ml) 20% (500ml) 50% (500ml) |
| 06.01.06 | GluNeo meter | |
| 01.06.02 | Glycerol (Glycerin) | Suppositories 1g 2g 4g |
| 02.06.01 | Glyceryl Trinitrate | Spray 400micrograms/dose; Buccal tablets 2mg, 3mg, 5mg; Sublingual tablets 500micrograms; Injection 50mg/50ml (hospital only) |
| 20 | Glyceryl Trinitrate 0.4% Ointment Rectogesic® | Approved by HaRD APC March 2017 for chondrodermatitis |
| 07.04.04 | Glycine | Irrigation solution 1.5% 3L |
| 15.01.03 | Glycopyrronium Bromide (Glycopyrrolate) Robinul® | |
| 13.12 | Glycopyrronium Bromide tablets | This is an UNLICENSED medicine |
| 01.05.03 | Golimumab Simponi | |
| 06.07.02 | Goserelin | Injection 3.6mg, 10.8mg Initiation on the advice of a specialist Not stocked at HDFT |
| 08.03.04.01 | Goserelin Zoladex® | Implant 3.6mg |
| 08.03.04.02 | Goserelin Zoladex® | |
| 04.06 | Granisetron 3.1mg/24 hour patches Sancuso® | Approved for an initial 6 month trial. Usage to be reviewed by the Area Prescribing Committee in July 2014 |
| 03.04.02 | Grass and Tree Pollen Extract Pollinex® | For immunotherapy Consultant use only |
| 03.04.02 | Grass pollen extract Grazax® | For immunotherapy Consultant use only |
| 04.04 | Guanfacine Intuniva | |
| 13.05.03 | Guselkumab | Added as NICE TA521 available - see link Not yet approved by the APC |
| 14.04 | Haemophilus influenzae type B | |
| 04.02.01 | Haloperidol | Tablets 1.5mg, 5mg, 10mg, 20mg Capsules 500 micrograms Liquid 2mg/ml Injection 5mg/ml |
| 04.02.02 | Haloperidol Haldol Decanoate® | Injection 50mg/ml, 100mg/ml |
| 17 | Haloperidol | Dose: 0.5mg - 2.5mg s/c every 6 hours prn max 10mg/24hrs |
| 13.02.01 | Heel Balm (Urea 25%) Flexitol® | Approved by HaRD Area Prescribing Committee June 2017. Initiated in the diabetic foot clinic only. Treatment stopped after 4 weeks if no benefit observed. |
| 24.01 | Heparin (unfractionated) |
|
| 24.16 | Heparinised saline Neonatal |
|
| 13.13 | Heparinoid 0.3% Hirudoid® | |
| 14.04 | Hepatitis A vaccine | |
| 14.05.02 | Hepatitis B immunoglobulin | |
| 14.04 | Hepatitis B vaccine | |
| 24.16 | Hepatitis B vaccine and immunoglobulin Neonatal |
|
| 20 | HRH Cream Pigmanorm® | Approved by the Area Prescribing Committee, April 2016 Prescriptions for all other strengths of HRH should be queried; agreed in Dermatology Quality of Care to only prescribe and dispense the 5% Pigmanorm preparation |
| 09.02.02.02 | Human Albumin Solution | Obtain from Haematology |
| 20 | Human chorionic gonadotrophin (ULM) | Approved by HaRD Area Prescribing Committee January 2019 for male fertility |
| 11.08.01 | Hyaluronic acid cross-linked (long-acting) VisuXL® | For patients with compliance problems as BD dosing |
| 10.03.01 | Hyaluronidase Hyalase® | Injection 1500 units |
| 02.05.01 | Hydralazine Hydrochloride | Injection 20mg |
| 01.05.02 | Hydrocortisone Colifoam® | 125mg /metered application |
| 06.03.02 | Hydrocortisone Hydrocortisab® | Hydrocortisone acetate 25mg/ml injection |
| 06.03.02 | Hydrocortisone Solu-Cortef® | Hydrocortisone sodium succinate 100mg injection |
| 24.16 | Hydrocortisone Neonatal |
|
| 13.04 | Hydrocortisone 0.25% Crotamiton 10% Eurax-Hydrocortisone® | Mild |
| 13.04 | Hydrocortisone 0.5%, nystation 100,000 units/g Benzalkonium Chloride Solution 0.2%, Dimeticone 350 10% Timodine® |
Mild |
| 13.04 | Hydrocortisone 1% with Clotrimazole 1% Canesten HC® | Mild |
| 13.04 | Hydrocortisone 1% with Miconazole Nitrate 2% Daktacort® | Mild |
| 10.01.02.02 | Hydrocortisone acetate Hydrocortistab® | Injection 25mg/ml |
| 13.04 | Hydrocortisone Acetate 1% with Fusidic Acid 2% Fucidin H® | Mild |
| 12.01.01 | Hydrocortisone Acetate 1% with Gentamicin 0.3% Gentisone® HC | Eye/Ear drops |
| 13.04 | Hydrocortisone cream | 0.5%, 1% and 2.5%
Mild |
| 24.01 | Hydrocortisone cream/ointment |
|
| 24.01 | Hydrocortisone injection |
|
| 13.11.06 | Hydrogen Peroxide 1% cream Crystacide® | |
| 20 | Hydroquinone 4% cream | Approved for one patient only, May 2016 |
| 09.01.02 | Hydroxocobalamin | Injection 1mg/ml |
| 08.01.05 | Hydroxycarbamide | |
| 10.01.03 | Hydroxychloroquine Sulphate Plaquenil® | Tablets 200mg |
| 03.04.01 | Hydroxyine Hydrochloride Atarax® | Tablets 10mg, 25mg |
| 03.04.01 | Hydroxyine Hydrochloride Ucerax® | 10mg/5ml syrup Note tablets are blacklisted. |
| 06.04.01.02 | Hydroxyprogesterone Unlicensed | Injection 250mg/ml Unlicensed medicine Initiation on the advice of a Consultant in Obs&Gynae |
| 20 | HYDROXYPROGESTERONE 250mg/ml inj | For use by Consultants in Obstetrics only |
| 01.02 | Hyoscine Butylbromide Buscopan® | 10mg tablets; 20mg/ml injection |
| 17 | Hyoscine butylbromide | |
| 24.01 | Hyoscine butylbromide |
|
| 03.07 | Hypertonic Saline 7% Nebules Nebusal® | Approved by the HaRD Area Prescribing Committee, January 2015 |
| 11.08.01 | Hypromellose | Eye drops 0.3% |
| 06.06.02 | Ibandronic Acid | 50mg tablets. (Note 150mg tablets remain non formulary) |
| 06.06.02 | Ibandronic Acid Bonviva® | Pre-filled syringe 3mg Initiation on the advice of a specialist |
| 08.01.05 | Ibrutinib Imbruvica® | Approved under the Cancer Drugs Fund, February 2015. Available in 90 and 120 capsule pack-sizes |
| 10.01.01 | Ibuprofen | Tablets 200mg, 400mg Liquid 100mg/5ml Gel 5% (50g) |
| 24.01 | Ibuprofen |
|
| 24.16 | Ibuprofen Neonatal |
|
| 20.01 | Idelalisib 100mg and 150mg tablets Zydelig® | Approved by the Area Prescribing Committee, November 2014 |
| 08.01.01 | Ifosfamide Mitoxana® | |
| 13.07 | Imiquimod Aldara® | |
| 24.16 | Immunisations Neonatal |
|
| 24.01 | Immunoglobulins |
|
| 24.16 | Immunoglobulins Neonatal |
|
| 02.02.01 | Indapamide | |
| 10.01.01 | Indometacin | Capsules 25mg, 50mg MR tablets 75mg |
| 24.01 | Infatrini | Paediatric Nutritional products list approved APC 05/18 |
| 24.01 | Infatrini Peptisorb | Paediatric Nutritional Products List - approved APC 05/18 |
| 01.05.03 | Infliximab Remicade® | Consultant request only |
| 10.01.03 | Infliximab Remicade® | Initiation on the advice of a specialist |
| 14.04 | Influenza vaccine | |
| 13.08.01 | Ingenol mebutate gel Picato® | Approved by HaRD APC April 2013. Not stocked at HDH. |
| 06.01.01.03 | Injection devices Clikstar | For glargine and glulisine cartridges |
| 06.01.01.03 | Injection Devices HumaPen® Luxura | |
| 06.01.01.03 | Injection Devices NovoPen® | |
| 06.01.01.01 | Insulin Actrapid® | Vial For use in the treatment of hyperkalaemia only |
| 06.01.01.01 | Insulin Humulin® S | Cartridge Vial |
| 24.16 | Insulin Neonatal |
50units in 50ml pre-filled syringe |
| 06.01.01.01 | Insulin Aspart NovoRapid® | Vial Cartridge Flexpen |
| 06.01.01.01 | Insulin Aspart Fiasp® | Vial |
| 24.01 | Insulin aspart (Novorapid) |
|
| 06.01.01.02 | Insulin Degludec Tresiba® | |
| 24.01 | Insulin degludec (Tresiba) |
|
| 06.01.02.03 | Insulin Degludec 100iu/mL and Liraglutide 3.6mg/mL Xultophy® | Approved by the Area Prescribing Committee for secondary care use only November 2015. |
| 06.01.01.02 | Insulin Detemir Levemir® | Cartridge Flexpen Long acting insulin analogue of choice for management of type 1 diabetes. |
| 24.01 | Insulin detemir (Levemir) |
|
| 24.01 | Insulin glargine (Abasaglar) |
|
| 06.01.01.02 | Insulin Glargine 100units/ml Lantus | Prescribe by Brand No longer recommended for new patients. Abasaglar is the brand of choice if insulin glargine is required. |
| 06.01.01.02 | Insulin Glargine 100units/ml (biosimilar) Abasaglar | Cartridge kwikpen Abasaglar has been shown to be equivalent to Lantus in its pharmacokinetic and pharmacodynamic properties. However, as with other biosimilar medicines, some dose adjustment may be needed for some patients. Biosimilar insulin glargine approved for use in place of Lantus. |
| 06.01.01.01 | Insulin Lispro Sanofi or Humalog® | Vial
**New patients should be commenced on biosimilar insulin lispro (Sanofi) |
| 24.01 | Insulin lispro (Humalog) |
|
| 09.03 | Intralipid 20% | 500ml |
| 07.03.04 | Intra-uterine Contraceptive Devices Flexi-T® + 300 | |
| 07.04.04 | Intravesical chondrotin & sodium hyaluronate bladder instillation iAluRil® | Approved by HaRD Area Prescribing Committee June 2014 |
| 06.02.02 | Iodine and Iodide Aqueous Iodine Oral Solution | Aqueous solution (Lugol's iodine) |
| 24.01 | Ipratropium |
|
| 03.01.02 | Ipratropium Bromide | Inhaler 20mcg/dose Nebules 250mcg/ml, 500mcg/2ml |
| 12.02.02 | Ipratropium Bromide Rinatec® | Nasal spray 0.03% |
| 02.05.05.02 | Irbesartan Aprovel ® | Tablets 75mg 150mg For use by specilaists only for diabetic nephropathy |
| 09.01.01.01 | Iron and Folic Acid Pregaday® | Tablets 100mg iron & 350micrograms folic acid |
| 09.01.01.02 | Iron Dextran CosmoFer® | Injection 50mg/ml Initiation on the advice of a Haematologist Use pre-printed chart |
| 09.01.01.02 | Iron Isomaltoside Monofer® |
100 mg/ml solution for injection/infusion. Refer to IV Iron Policy |
| 09.01.01.02 | Iron Sucrose Venofer | Injection 20mg/ml Use pre-printed chart |
| 15.01.02 | Isoflurane | |
| 24.16 | Isoniazid Neonatal |
|
| 06.01.01.02 | Isophane Insulin Pork Hypurin® | Cartridge |
| 06.01.01.02 | Isophane Insulin Insulatard® | Cartridge Innolet pen |
| 06.01.01.02 | Isophane Insulin Humulin® I | Cartridge Kwikpen |
| 02.07.01 | Isoprenaline Sulphate Unlicensed Medicine | Stock kept on ITU only |
| 02.06.01 | Isosorbide Dinitrate | Injection 10mg/10ml For use in Cardiac Unit only |
| 02.06.01 | Isosorbide Mononitrate |
See NICE CG126: stable angina |
| 13.06.01 | Isotretinoin Isotrex Gel® | |
| 13.06.02 | Isotretinoin | Capsules |
| 01.06.01 | Ispaghula Husk | Sachets 3.5g |
| 02.06.03 | Ivabradine Procoralan® |
|
| 20.01 | Ivermectin 10mg/g cream Soolantra® | Apply daily and discontinue after 3 months if there is no response. |
| 13.01 | Ixekizumab 80mg solution for injection Taltz® | Approved by the Area Prescribing Committee, January 2017 |
| 15.01.01 | Ketamine Ketalar® | |
| 13.09 | Ketoconazole Shampoo | |
| 06.01.06 | Ketones Ketostix® | |
| 01.06.05 | Klean-Prep® | |
| 02.04 | Labetalol Hydrochloride | Tablets 100mg, 200mg; Injection 100mg/20ml (hospital only) |
| 04.08.01 | Lacosamide Vimpat ® | Tablets 50mg Initiation on the advice of a specialist |
| 01.06.04 | Lactulose | For alcohol induced encephalopathy only |
| 24.01 | Lactulose |
|
| 04.08.01 | Lamotrigine | Tablets 25mg, 50mg, 100mg, 200mg Dispersible tablets 5mg, 25mg Initiation on the advice of a Neurologist |
| 13.05.03 | lanadelumab Takhzyro | Added as TA606 available. See link
|
| 01.03.05 | Lansoprazole | Capsules 15mg 30mg; |
| 01.03.05 | Lansoprazole | FasTabs 15mg 30mg for administration down enteral feeding tubes only |
| 24.01 | Lansoprazole |
|
| 09.05.02.02 | Lanthanum Fosrenol ® | Chewable tablets 500mg, 750mg Initiation on the advice of a Renal Specialist |
| 11.06 | Latanoprost Xalatan® | Eye drops 50micrograms/ml |
| 11.06 | Latanoprost 0.005% with Timolol 0.5% Xalacom® | Eye drops (latanoprost 50micrograms/ml & timolol 0.5%) |
| 10.01.03 | Leflunomide Arava® | Tablets 10mg |
| 08.02.04 | Lenalidomide Revlimid® | Patient authorisation form must be sent with each prescription Capsules 10mg, 15mg, 25mg |
| 08.03.04.01 | Letrozole Femara® | Tablets 2.5mg |
| 06.07.02 | Leuprorelin Acetate Prostap® | Injection 3.75mg, 11.25mg Approved in line with Leeds shared care guidelines in March 2014 for the initiation on the advice of a specialist. Not stocked at HDFT |
| 04.08.01 | Levetiracetam | Tablets 250mg, 500mg, 1000mg |
| 24.01 | Levetiracetam |
|
| 15.02 | Levobupivacaine Chirocaine® | |
| 15.02 | Levobupivacaine with Fentanyl | |
| 05.01.12 | Levofloxacin Tavanic® | |
| 11.03.01 | levofloxacin Oftaquix® | Eye drops 0.5% |
| 17 | Levomepromazine | Dose for agitation/distress: 25mg s/c every 3 hours prn Dose for nausea: 6.25mg - 12.5mg s/c every 3 hours prn |
| 07.03.05 | Levonogrestrel Levonelle® 1500 | Tablet Levonorgestrel 1.5mg To be used up to 72hours after unprotected sexual intercourse |
| 07.03.02.03 | Levonorgestrel 13.5mg intrauterine system Jaydess® | Approved by HaRD Area Precribing Committee June 2014 |
| 07.03.02.03 | Levonorgestrel 20 microgram/24 hours Intrauterine Delivery System Levosert® | Approved by APC December 2019 Prescribe by brand |
| 07.03.02.03 | Levonorgestrel 20mg intrauterine system Mirena® | Prescribe by brand |
| 06.02.01 | Levothyroxine Sodium Levothyroxine | Tablets 25micrograms, 50micrograms, 100micrograms Liquid 25micrograms/5ml |
| 24.16 | Lidocaine Neonatal |
|
| 15.02 | Lidocaine 2.5% with Prilocaine 2.5% Cream EMLA or Denela® | |
| 15.02 | Lidocaine HCl 2% with Chlorhexidine gluconate 0.25% gel Instillagel or Optilube Active® | |
| 15.02 | Lidocaine HCl with Adrenaline | |
| 02.03.02 | Lidocaine Hydrochloride | Infusion 0.1%, 0.2% in glucose 5% |
| 02.03.02 | Lidocaine Hydrochloride Minijet® Lignocaine | 100mg/5ml |
| 15.02 | Lidocaine Hydrochloride | |
| 15.02 | Lidocaine hydrochloride LMX 4® | |
| 12.03.01 | Lidocaine Hydrochloride 2%, Chlorhexidine Gluconate Solution 0.25% Instillagel® | |
| 15.02 | Lidocaine Patch Versatis® | In exceptional circumstances only - this can be used on a named patient basis by the specialist pain team - December 2017 APC |
| 01.06.07 | Linaclotide Constella® | Approved for one patient only - September 2014 |
| 06.01.02.03 | Linagliptin Trajenta® | Tablets 5mg For patients with CKD 3 or 4 (GFR <50ml/min) |
| 05.01.07 | Linezolid | For use on microbiology advice ONLY |
| 06.02.01 | Liothyronine Sodium | Injection 20micrograms |
| 13.02.01 | Liquid and White Soft Paraffin Ointment (50:50) | 500g |
| 01.06.03 | Liquid Paraffin | |
| 11.08.01 | Liquid Paraffin Xailin Night® or VitA Pos® | Eye ointment |
| 06.01.02.03 | Liraglutide Victoza® | Pre-filled pen 18mg/3ml Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber). |
| 04.04 | Lisdexamfetamine Elvanse | |
| 02.05.05.01 | Lisinopril | Tablets 2.5mg 5mg 10mg 20mg |
| 04.02.03 | Lithium Carbonate Priadel® | MR tablets 200mg, 400mg Specify brand to avoid confusion between different formulations of lithium |
| 04.02.03 | Lithium Citrate Priadel® | Liquid 520mg/5ml Specify brand to avoid confusion between different formulations of lithium |
| 06.01.02.03 | Lixisenatide Lyxumia® | Approved by HaRD APC April 2013 Seek advice from the Specialist Diabetes Team where GLP-1 is being added with insulin in Type-2 diabetes (Amber). |
| 04.03.01 | Lofepramine | Tablets 70mg Liquid 70mg/5ml |
| 04.10 | Lofexidine Hydrochloride BritLofex® | Tablets 200micrograms |
| 08.01.01 | Lomustine | |
| 01.04.02 | Loperamide Hydrochloride | Capsules 2mg; Syrup 1mg/5ml |
| 03.04.01 | Loratadine | Formulary in Primary Care (First-line Option) Non-Formulary at HDFT |
| 04.01.02 | Lorazepam | Tablets 1mg Injection 4mg/ml |
| 04.08.02 | Lorazepam | Injection 4mg/ml An unlicensed preparation is currently in use due to a long-term manufacturing problem with the UK licensed injection. Restricted use |
| 24.01 | Lorazepam |
|
| 02.05.05.02 | Losartan Potasium Cozaar® | Tablets 25mg, 50mg |
| 03.01.05 | Low range peak flow meter Mini-Wright® | |
| 01.06.07 | Lubiprostone Amitiza® | Approved by the Area Prescribing Committee September 2014 in line with NICE TA318 |
| 20 | Lugols Iodine | |
| 24.01 | Macrogol sachets |
|
| 01.06.04 | Macrogols Movicol® Paediatric Pain | |
| 01.06.04 | Macrogols Laxido® | |
| 09.05.01.03 | Magnesium Aspartate | Sachets 10mmol |
| 24.01 | Magnesium sulfate (acute asthma) |
|
| 09.05.01.03 | Magnesium Sulphate | Injection 50% (2mmol/ml) Infusion 20% (Delivery Suite only) |
| 24.16 | Magnesium sulphate Neonatal |
|
| 13.10.05 | Magnesium Sulphate Paste BP | |
| 01.01.01 | Magnesium Trisilicate Mixture BP | |
| 13.10.04 | Malathion 0.5% Derbac-M® | |
| 02.02.05 | Mannitol | Infusion 10% 20% |
| 20 | Measles, Mumps & Rubella Vaccine, Live MMR® | Approved by the HaRD Area Prescribing Committee, March 2015 for the treatment of viral warts. To be recommended by a Dermatologist only |
| 14.04 | Measles, Mumps and Rubella Vaccine, Live (MMR) | |
| 01.02 | Mebeverine Hydrochloride | Tablets 135mg |
| 13.02.02 | Medi-Derma S Barrier Cream | |
| 06.04.01.02 | Medroxyprogesterone Acetate Sayana Press® | Medicine is licensed for self-administration - patients should be trained to self -administer by the practice nurses. Sharps bin will need prescribing. 104 mg/0.65 ml suspension for injection. |
| 06.04.01.02 | Medroxyprogesterone Acetate Provera® / Depo-Provera | Tablets 5mg, 100mg Depot injection 150mg/ml Initiation on the advice of a specialist |
| 07.03.02.02 | Medroxyprogesterone Acetate Depo-Provera® | Injection 150mg/ml |
| 07.03.02.02 | Medroxyprogesterone Acetate Sayana Press®. | Medicine is licensed for self-administration - patients should be trained to self -administer by the practice nurses. Sharps bin will need prescribing. 104 mg/0.65 ml suspension for injection. |
| 08.03.02 | Medroxyprogesterone Acetate Provera® | |
| 10.01.01 | Mefenamic Acid | Tablets 500mg |
| 08.03.02 | Megestrol Acetate Megace® | |
| 04.01.01 | Melatonin Circadin ® | MR tablets 2mg For initiation by Consultant Neurologists only. |
| 04.01.01 | Melatonin | Use Circadin tablets - crush and mix with soft food. |
| 08.01.01 | Melphalan Alkeran® | Tablets 2mg |
| 04.11 | Memantine Hydrochloride Ebixa® | |
| 09.06.06 | Menadiol Sodium Phosphate | Tablets 10mg (long-term manufacturing problem. Phytomenadione 1mg available) |
| 14.04 | Meningococcal group C conjugate vaccine Meningitec® | |
| 24.16 | Meningococcal group C conjugate vaccine Neonatal |
primary immunisation schedule |
| 14.04 | Meningococcal polysaccharide A, C, W135 and Y vaccine ACWY Vax® | |
| 13.03 | Menthol 1% in aqueous cream Menthol in aqueous cream | 100g and 500g Brands include Arjun and Dermacool |
| 03.08 | Menthol and Eucalyptus Inhalation BP 1980 | |
| 03.04.02 | Mepolizumab Nucala® | Injection 100mg For use by Respiratory consultants only |
| 04.07.02 | Meptazinol Meptid® | Tablets 200mg Injection 100mg/ml For use in obstetric analgesia only |
| 08.01.03 | Mercaptopurine Puri-Nethol® | |
| 01.05.03 | Mercaptopurine tablets Puri-Nethol® | Maintenance of remission of acute ulcerative colitis and Crohn’s disease in adults (unlicensed) |
| 05.01.02.02 | Meropenem Meronem® | Injection 1g powder Indicated for: Neutropenic Sepsis in patients with a non-severe penicillin allergy. Microbiology advice should be sought for all other indications. |
| 24.01 | Meropenem |
On the advice of Microbiology |
| 24.16 | Meropenem Neonatal |
|
| 05.01.07 | Meropenem trihydrate and vaborbactam | For the treatment of:
On microbiology advice, for the treatment of infections due to aerobic Gram negative organisms where there are limited treatment options. Approved APC June 2020 |
| 01.05.01 | Mesalazine Octasa® | Tablets 400mg, 800mg - Asacol brand (for doses over 2.4g daily only); Foam enema 1g; Suppositories 500mg |
| 01.05.01 | Mesalazine Pentasa® | MR tablets 500mg; Retention enema 1g/100ml; Suppositories 1g |
| 01.05.01 | Mesalazine Mezavant® XL | MR tablets 1.2g For use by Consultant Gastroenterologists only, for patients non-compliant with other oral mesalazine preparations. |
| 08.01 | Mesna Uromitxan® | |
| 24.01 | Metabolic formulary |
|
| 24.16 | Metanium Neonatal |
|
| 06.01.02.02 | Metformin Hydrochloride Metformin® | Tablets 500mg, 850mg Sachets 500mg |
| 06.01.02.02 | Metformin Hydrochloride Glucophage® SR | MR tablets 500mg, 750mg Initiation on the advice of a specialist |
| 04.10 | Methadone Hydrochloride | Mixture 1mg/ml Initiation on the advice of a Consultant Psychiatrist |
| 05.01.13 | Methenamine Hippurate Hiprex® | On the advice of Microbiology |
| 08.01.03 | Methotrexate | Tablets 2.5mg Injection 10mg, 12.5mg, 15mg, 17.5mg, 20mg, 22.5mg, 25mg, 30mg, 50mg, 75mg |
| 10.01.03 | Methotrexate Rheumatology | Tablets 2.5mg |
| 13.05.03 | Methotrexate | |
| 13.08.01 | Methyl-5-Aminolevulinate Metvix® | |
| 01.06.06 | Methylnaltrexone Relistor® | Injection 12mg For Palliative Care Consultants only |
| 24.01 | Methylphenidate |
|
| 04.04 | Methylphenidate Hydrochloride Medikinet | Tablets 10mg Initiation on the advice of a specialist |
| 10.01.02.02 | Methylprednisolone Acetate Depo-Medrone® | Injection 40mg/ml, 80mg/2ml, 120mg/3ml |
| 10.01.02.02 | Methylprednisolone Acetate Depo-Medrone® with Lidocaine | Injection Methylprednisolone 40mg /lidocaine 10mg/ml |
| 01.02 | Metoclopramide | Tablets 10mg; Syrup 5mg/5ml See section 4.6 |
| 17 | Metoclopramide | Dose: 10mg - 20mg s/c every 6 hours prn |
| 24.01 | Metoclopramide |
|
| 04.06 | Metoclopramide Hydrochloride | Tablets 10mg Liquid 5mg/5ml Injection 10mg/2ml |
| 02.02.01 | Metolazone Unlicensed | |
| 02.04 | Metoprolol Tartrate | Tablets 50mg |
| 05.01.11 | Metronidazole | Tablets 200mg, 400mg Liquid 200mg/5ml Suppositories 500mg, 1g |
| 24.01 | Metronidazole |
|
| 24.16 | Metronidazole Neonatal |
|
| 13.10.01.02 | Metronidazole 0.75% Gel | Brands include Anabact and Metrosa |
| 12.03.02 | Miconazole Daktarin® | Oral gel 20mg/g |
| 13.10.02 | Miconazole Nitrate | |
| 24.16 | Miconazole oral gel / topical cream (Daktarin®) Neonatal |
|
| 04.08.02 | Midazolam Buccolam® | Buccal liquid - Pre-filled syringes (4) 2.5mg, 5mg, 7.5mg, 10mg 3 to 6 months(Hospital setting) 2.5mg in 0.5ml (Yellow) >6 months to <1 year 2.5mg in 0.5ml (Yellow) 1 year to <5 years 5mg in 1ml (Blue) 5 years to <10 years 7.5mg in 1.5ml (Purple) 10 years to <18 years 10mg in 2ml (Orange) |
| 15.01.04.01 | Midazolam | |
| 17 | Midazolam | Dose: 2.5mg - 5mg s/c every 1 hour prn. |
| 24.16 | Midazolam Neonatal |
|
| 24.01 | Midazolam buccal (Buccolam) |
|
| 24.01 | Midazolam injection |
|
| 02.07 | Midodrine Unlicensed | Tablets 5mg For use by specialists only |
| 20 | MIDODRINE Tablets 2.5 mg, 5mg | For use in postural hypotension if licensed options have failed e.g. fludrocortisone |
| 07.01.02 | Mifepristone Mifegyne® | Tablets 200mg |
| 07.04.02 | Mirabegron Betmiga® | Approved by HaRD APC July 2013 |
| 04.03.04 | Mirtazapine | Tablets 15mg, 30mg |
| 08.01.02 | Mitomycin Mitomycin C Kyowa® | |
| 20 | Mitomycin-C | 0.2mg/1ml 0.4mg/1ml Approved by HaRD Area Prescribing Committee June 2014 For Consultant Ophthalmolgist use only |
| 08.01.02 | Mitoxantrone (Mitozantrone) | |
| 15.01.05 | Mivacurium Chloride Mivacron® | |
| 04.04 | Modafinil Provigil® | Tablets 100mg |
| 12.02.01 | Mometasone Furoate Nasonex® | Nasal spray 50micrograms/metered spray |
| 13.04 | Mometasone Furoate 0.1% Elocon® | Cream 30g, 100g Potent |
| 03.03.02 | Montelukast Singulair® | Tablets 10mg Chewable tablets 4mg, 5mg Granules 4mg For initiation by respiratory specialists only |
| 24.01 | Montelukast |
|
| 24.01 | Morphine |
|
| 03.09.01 | Morphine Hydrochloride | |
| 04.07.02 | Morphine Sulphate | MR tablets 10mg, 30mg, 60mg, 100mg (Zomorph preferred choice in primary care) Liquid 10mg/5ml, 100mg/5ml Injection 10mg/ml, 15mg/ml Syringe for PCA 50mg/50ml Oral solution 100micrograms/ml(for use in SCBU) |
| 24.16 | Morphine sulphate Neonatal |
|
| 20 | Morphine sulphate 100mg/100ml | |
| 09.05.03 | Mouthwash tablets Tellodont® | Soluble tablets |
| 12.03.04 | Mouthwash tablets | |
| 11.03.01 | Moxifloxacin 0.1mg/0.1ml (unlicensed) | Intracameral injection. Antibacterial prophylaxis in cataract surgery where cefuroxime is contra-indicated. Approved by HaRD Area Prescribing Committee Feb 2014 |
| 02.05.02 | Moxonidine | Tablets 200micrograms For use by a specialist only |
| 13.10.01.01 | Mupirocin Bactroban® | |
| 12.02.03 | Mupirocin 2% in White Soft Paraffin Bactroban Nasal® | Nasal ointment 2% |
| 09.06.07 | Mutivitamin | Tablets |
| 08.02.01 | Mycophenolate Mofetil | Prescribe generically |
| 02.06.04 | Naftidrofuryl Oxalate | Formulary as per NICE TA223 |
| 04.10.01 | Nalmefene Selincro | To be prescribed by the community alcohol service provided by North Yorkshire Horizons only. |
| 01.06.06 | Naloxegol oxalate Moventig® | 12.5mg and 25mg tablets |
| 24.16 | Naloxone Neonatal |
|
| 15.01.07 | Naloxone Hydrochloride Naloxone® | |
| 10.01.01 | Naproxen | Tablets 250mg Switched to HDFT NSAID of choice November 2012 due to increased CV risk with diclofenac |
| 06.01.02.03 | Nateglinide Starlix® | Tablets 120mg Initiation on the advice of a specialist |
| 02.04 | Nebivolol Nebilet® | Cardiology initiation only |
| 11.04.02 | Neodocromil Sodium Rapitil® | Eye drops 2% |
| 10.02.01 | Neostigmine | Injection 2.5mg/ml |
| 15.01.06 | Neostigmine Metilsulfate | |
| 15.01.06 | Neostigmine Metilsulfate with Glycopyrronium Robinul-Neostigmine® | |
| 02.06.03 | Nicorandil Ikorel® | |
| 09.06.02 | Nicotinamide | Nicotinamide is recomended by the HaRD APC (Feb 2020) for the prevention of non- melanoma skin cancers in high risk patients, those with multiple previous skin cancers +/- immunosuppression. However the APC does NOT authorise the prescribing of this product. The APC recommends patients be advised to purchase this product Over The Counter. |
| 04.10 | Nicotine Niquitin CQ® patches | Patches, 7mg, 14mg and 21mg strength |
| 02.06.02 | Nifedipine | Capsules 5mg, 10mg |
| 02.06.02 | Nifedipine Adalat® LA | MR tablets 20mg, 30mg, 60mg (once daily dosing) Prescribe by brand |
| 02.06.02 | Nifedipine Coracten® SR | MR capsules 10mg (twice daily dosing) Prescribe by brand |
| 02.06.02 | Nifedipine Adalat® Retard | MR tablets 10mg, 20mg (twice daily dosing) Prescribe by brand |
| 08.01.05 | Nilotinib Tasigna® | |
| 04.01.01 | Nitrazepam | Tablets 5mg Liquid 2.5mg/ml |
| 05.01.13 | Nitrofurantoin | Tablets 100mg Capsules 50mg Liquid 25mg/5ml MR capsules 100mg |
| 24.01 | Nitrofurantoin |
|
| 15.01.02 | Nitrous oxide | |
| 24.01 | Nitrous Oxide (Entonox) |
|
| 24.01 | Noradrenaline |
|
| 24.16 | Noradrenaline Neonatal |
|
| 02.07.02 | Noradrenaline Acid Tartrate / Norepinephrine Bitartrate Noradrenaline ®/ Norepinephrine | Injection 2mg/ml (equivalent to noradrenaline base 1mg/ml) |
| 06.04.01.02 | Norethisterone | Tablets 5mg Initiation on the advice of a specialist |
| 08.03.02 | Norethisterone | |
| 14.05.01 | Normal Immunoglobulin for Intravenous use Privigen® | There is a National Immunoglobulin Database which must be updated for every patient commenced on immunoglublin therapy. Sections 1-3 of the attached immunoglobulin request form must be completed by the requesting clinician and sent to Pharmacy Aseptics. |
| 24.01 | Nutrini | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Nutrini Energy | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Nutrini Energy Mulifibre | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Nutrini Multifibre | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Nutrini Peptisorb | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Nutrini Peptisorb Energy | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.16 | Nutriprem 2 Neonatal |
|
| 16.01 | Nutrison Multifibre | Refeeding protocol approved APC July 2018 - see link |
| 12.03.02 | Nystatin Nystan® | Oral solution 100 000units/ml |
| 24.16 | Nystatin Neonatal |
Oral liquid Topical cream discontinued |
| 01.09.01 | Obeticholic acid Ocaliva® | |
| 11.08.02 | Ocriplasmin 0.5 mg/0.2 ml concentrate for solution for injection Jetrea | Administered by intravitreal injection only |
| 24.16 | Octenisan Neonatal |
|
| 08.03.04.03 | Octreotide Sandosatin® | Injection 50micrograms/ml, 100micrograms/ml Initiation on teh advice of a specialist |
| 08.03.04.03 | Octreotide Sandosatin Lar® | Injection 10mg Initiation on the advice of a specialist |
| 06.04.01.01 | Oestrogens for HRT Premique® | All oestrogen and HRT products should only be prescribed on the advice of a specialist. Always consider lowest dose possible - refer new patients to GP for Premique low dose. |
| 06.04.01.01 | Oestrogens for HRT Prempak-C® | Tablets 1.25 Initiation on the advice of a specialist |
| 06.04.01.01 | Oestrogens for HRT Premarin® | Tablets 625micrograms Initiation on the advice of a specialist |
| 06.04.01.01 | Oestrogens for HRT Climaval® | Approved by the Area Prescribing Committee, February 2015 1mg and 2mg tablets available. |
| 06.04.01.01 | Oestrogens for HRT Evorel® | Patch 50micrograms/24 hours If patient experiences skin irritation from the patches, refer to GP for matrix patches |
| 07.02.01 | Oestrogens, Topical Ortho-Gynest® | Pessaries 500micrograms |
| 07.02.01 | Oestrogens, Topical Gynest® | Intravaginal cream 0.01% Only for patients who have had a reaction to Ovestin - Jan APC 2020 |
| 07.02.01 | Oestrogens, Topical Ovestin® | Intravaginal estriol cream 0.1% 1st line - Jan 2020 APC |
| 08.02.03 | Ofatumumab Arzerra® | Approved by the HaRD Area Prescribing Committee, March 2015 |
| 11.03.01 | Ofloxacin Exocin® | Eye drops 0.3% |
| 04.02.01 | Olanzapine Zyprexa® | Tablets 2.5mg, 5mg, 10mg Orodispersible tablets 5mg, 10mg |
| 12.01.03 | Olive Oil | |
| 03.04.02 | Omalizumab Xolair® | Injection 150mg For use by respiratory consultants only |
| 01.03.05 | Omeprazole | Capsules 10mg 20mg |
| 24.01 | Omeprazole |
|
| 24.16 | Omeprazole Neonatal |
|
| 01.03.05 | Omeprazole IV | |
| 04.06 | Ondansetron | Tablets 4mg, 8mg Liquid 4mg/5ml Injection 4mg/2ml, 8mg/4ml |
| 24.01 | Ondansetron |
|
| 04.09.01 | Opicapone Ongentys® | Approved by the Area Prescribing Committee, January 2017 Second line treatment option for patients unable to tolerate entacapone or where it is contraindicated. |
| 07.03.02 | Oral Progestogen-Only Contraceptives Morningside® | Tablets Desogestrel 75micrograms |
| 07.03.02 | Oral Progestogen-Only Contraceptives Micronor® | Tablets Norethisterone 350micrograms |
| 07.03.02 | Oral Progestogen-Only Contraceptives Norgeston® | Tablets Levonorgestrel 30micrograms |
| 24.01 | Oral rehydration sachets |
|
| 09.02.01.02 | Oral Rehydration Salts | Plain/Blackcurrant flavour |
| 04.05.01 | Orlistat Xenical® | Capsules 120mg Initiation on the advice of a specialist |
| 05.03.04 | Oseltamivir Tamiflu® | On the advice of a Microbiologist |
| 08.01.05 | Oxaliplatin | |
| 04.01.02 | Oxazepam | Tablets 10mg, 15mg For alcohol detoxification if impaired liver function |
| 11.07 | Oxybuprocaine Hydrochloride Minims® | Eye drops 0.4% |
| 07.04.02 | Oxybutynin Hydrochloride | Crush tablets for patients with swalloeing difficulties or in children |
| 17 | Oxycodone | Opiate of choice in moderate renal function |
| 04.07.02 | Oxycodone Hydrochloride OxyContin® | MR tablets 5mg, 10mg, 40mg, 80mg For regular TWICE DAILY dosing Morphine is first line strong opioid of choice |
| 04.07.02 | Oxycodone Hydrochloride OxyNorm® | Standard release capsules 5mg, 10mg (PRN for breakthrough pain) Liquid 5mg/5ml (250ml bottles) Liquid 50mg/5ml (120ml bottles) Injection 10mg/ml, 20mg/2ml, 50mg/ml |
| 05.01.03 | Oxytetracycline | Tablets 250mg |
| 07.01.01 | Oxytocin Syntocinon® | Injection 5units/ml, 10units/ml |
| 08.01.05 | Paclitaxel | |
| 04.02.02 | Paliperidone Xeplion | 50mg, 75mg, 100mg, 150mg prefilled syringe |
| 24.16 | Palivizumab Neonatal |
|
| 04.06 | Palonosetron with netupitant Akynzeo® | Approved by HaRD APC April 2017 |
| 01.09.04 | Pancreatin Creon® 10000 | |
| 01.09.04 | Pancreatin Creon® 40000 | |
| 01.09.04 | Pancreatin Creon® 25000 | |
| 24.16 | Pancuronium Neonatal |
|
| 15.01.05 | Pancuronium Bromide | |
| 14.04 | Pandemic Influenza A(H1N1)v vaccine Celvapan® | |
| 08.01.05 | Panitumumab ® | |
| 04.07.01 | Paracetamol | Tablets 500mg, Soluble tablets 500mg Suppositories 60mg, 120mg, 250mg, 500mg Liquid 120mg/5ml, 250mg/5ml Intravenous infusion 10mg/ml* * Restricted |
| 04.08.03 | Paracetamol | For formulations see under Analgesics |
| 24.01 | Paracetamol |
|
| 24.16 | Paracetamol Neonatal |
|
| 04.07.01 | Paracetamol and codeine Co-codamol® 8/500 | Tablets Soluble tablets |
| 04.07.01 | Paracetamol and codeine Co-codamol® 30/500 | Tablets |
| 04.07.01 | Paracetamol and dihydrocodeine Co-dydramol® | Tablets 10/500 |
| 20 | PARAFFIN WHITE SOFT BP 350g | |
| 24.01 | Paraldehyde & oilve oil enema |
Unlicensed |
| 20 | PARALDEHYDE 50% in olive oil enema 30ml | |
| 15.01.04.02 | Parecoxib Dynastat® | |
| 07.03.02.02 | Parenteral Progestogen Only Contraceptives Nexplanon® | Implant Etonorgestrel 68mg |
| 04.03.03 | Paroxetine | Tablets 20mg, 30mg Liquid 10mg/5ml |
| 20 | PATENT BLUE Injection 2.5% | |
| 09.02.01.01 | patiromer | Use in renal patients must be approved by a renal consultant Awaiting further information for prescribing in Cardiology |
| 09.01.06 | Pegfilgrastim Neulasta® | Pre-filled syringe 6mg/0.6ml Initiation by Consultant Haematologist/Oncologist only |
| 08.01.05 | Pembrolizumab Keytruda® | |
| 08.01.03 | Pemetrexed Alimta® | |
| 07.04.03 | Pentosan Polysulfate Sodium 100mg capsules Elmiron® | Added as TA610 available
|
| 02.06.04 | Pentoxifylline Trental® | |
| 01.02 | Peppermint Oil Mintec® | Capsules e/c 0.2ml |
| 01.02 | Peppermint water | |
| 20 | PEPPERMINT WATER BP | |
| 01.01.02 | Peptac | |
| 04.08.01 | Perampanel Fycompa® | Initiation on the advice of a Specialist |
| 02.05.05.01 | Perindopril erbutine | Tablets 2mg 4mg For use by specialists in stroke patients only Perindopril Erbutine only |
| 13.10.04 | Permethrin | |
| 04.07.02 | Pethidine Hydrochloride | Injection 50micrograms/ml, 100micrograms/2ml |
| 04.08.01 | Phenobarbital | Tablets 30mg Liquid 50mg/5ml (alcohol free) Injection 30mg/ml, 200mg/ml |
| 24.01 | Phenobarbital (Phenobarbitone) |
|
| 24.16 | Phenobarbital (Phenobarbitone) Neonatal |
|
| 05.01.01.01 | Phenoxymethylpenicillin | Tablets 250mg Syrup 125mg/5ml & 250mg/5ml |
| 24.01 | Phenoxymethylpenicillin |
|
| 24.16 | Phenylephrine 2.5% minims Neonatal |
|
| 11.05 | Phenylephrine Hydrochloride Minims® Phenylephrine Hydrochloride | Eye drops 2.5%, 10% |
| 04.08.01 | Phenytoin | Phenytoin sodium Tablets 100mg, Chewable tablets 50mg Capsules 25mg, 50mg, 100mg Injection 250mg/5ml Phenytoin Liquid 30mg/5ml (Phenytoin sodium 100mg = Phenytoin 90mg) |
| 24.01 | Phenytoin |
|
| 24.16 | Phenytoin Neonatal |
|
| 03.09.01 | Pholcodine Linctus, BP | Liquid 5mg/5ml |
| 09.02 | Phosphate Infusion Polyfuser | See link to hypophosphataemia guidelines |
| 09.05.02.01 | Phosphate supplements | Effervescent tablets (Phosphate Sandoz): Phosphate 16.1mmol, Potassium 3.1mmol, Sodium 20.4mmol per tablet Polyfusor (500ml): Phosphate 50mmol, Potassium 9.5mmol, Sodium 81mmol in 500ml |
| 01.06.04 | Phosphates (Rectal) Fleet® Ready to use Enema | |
| 09.06.06 | Phytomenadione Konakion® MM | Injection 10mg/ml |
| 09.06.06 | Phytomenadione Konakion® MM Paediatric | Injection (can be used orally) 2mg/0.2ml |
| 11.06 | Pilocarpine | Eye drops 1%, 2%, 4% Minims 4% |
| 13.05.03 | Pimecrolimus Elidel® | |
| 06.01.02.03 | Pioglitazone Actos® | Tablets 30mg Initiation on the advice of a specialist |
| 05.01.01.04 | Piperacillin and Tazobactam | Injection 4.5g powder Should be prescribed as 'piperacillin/tazobactam' to identify it as a penicillin. Approved Indications: Hospital Acquired Pneumonia (HAP) Ventilator Associated Pneumonia (VAP) Aspiration Pneumonia Neutropenic Sepsis Microbiology advice should be sought for all other indications |
| 03.11 | Pirfenidone | |
| 05.01.01.05 | Pivmecillinam Selexid® | Tablets 200mg |
| 04.07.04.02 | Pizotifen | Tablets 500micrograms |
| 01.06.05 | Plenvu® | Approved January 2020 APC |
| 14.04 | Pneumococcal polysaccharide conjugate vaccine (13-valent adsorbed) Prevenar 13® | |
| 14.04 | Pneumococcal polysaccharide vaccine Pneumovax® II | |
| 24.16 | Pneumococcal vaccine (Prevenar13) Neonatal |
|
| 13.07 | Podophyllotoxin Warticon® | |
| 06.01.06 | Polycal | |
| 09.02.01.01 | Polystyrene Sukphonate Resins Calcium Resonium® | Oral powder |
| 08.02.04 | Pomalidomide Imnovid® | |
| 24.16 | Poractant alfa (Curosurf) Neonatal |
|
| 05.02.01 | Posaconazole | 100mg Tablets Microbiology approval only |
| 09.02.01.01 | Potasium Chloride Sando-K® | Effervescent tablets (12mmol potassium) |
| 09.02.01.01 | Potasium Chloride Slow-K® | MR tablets 600mg (8mmol potassium) MR tablets only to be prescribed if effervescent tablets or liquid preparations are inappropriate. Branded proect has been discontinued only specialsare available to order - these may be expensive. |
| 09.02.01.01 | Potasium Chloride Kay-Cee-L® | Liquid 1mmol/ml potassium |
| 09.02.02.01 | Potassium Chloride and Glucose Intravenous Infusion | Potassium 0.15%(20mmol), Glucose 5% (1000ml) Potassium 0.3%(40mmol), Glucose 5% (1000ml) Potassium 0.3%(40mmol), Glucose 10% (500ml) |
| 09.02.02.01 | Potassium Chloride and Sodium Chloride Intravenous Infusion | Potassium 0.15%(20mmol), NaCl 0.9% (1000ml) Potassium 0.3%(40mmol), NaCl 0.9% (1000ml) Potassium 0.45%(60mmol), NaCl 0.9% (1000ml) *Potassium 0.6%(80mmol), NaCl 0.9% (500ml)* *ECG monitoring required |
| 09.02.02.01 | Potassium Chloride Concentrate (Sterile) | Pre-filled syringe 50mmol/50ml For use on ITU only |
| 09.02.02.01 | Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion | Potassium 0.15%(20mmol),NaCl 0.45%,Glucose 5% (500ml) Potassium 0.3%(40mmol),NaCl 0.18%,Glucose 4% (1000ml) Potassium 0.3%(40mmol),NaCl 0.45%,Glucose 5% (500ml) *Potassium 0.15%(20mmol),NaCl 0.18%,Glucose 4% (500ml) *SCBU only |
| 07.04.03 | Potassium Citrate | Mixture 200ml |
| 13.11.06 | Potassium Permanganate Permitabs® | |
| 11.08.02 | Povidone iodine 5% single dose eye drops Minims® | |
| 13.11.04 | Povidone-Iodine Videne® | |
| 04.09.01 | Pramipexole | Tablets 180micogram base (= 250micogram salt), 700micogram base (= 1000microgram salt) Initiation on the advice of a specialist MR formulation: Individual patient request required through LPG. Preferred product of choice in primary care is Pipexus MR |
| 02.09 | Prasugrel Efient® | Tablets 5mg, 10mg For use by a specialist only |
| 02.12 | Pravastatin Sodium | Tablets 10mg, 20mg Use if adverse effects with simvastatin |
| 01.05.02 | Prednisolone Predfoam® | Foam enema 20mg |
| 01.05.02 | Prednisolone Predsol | Retention enema 20mg/100ml |
| 01.05.02 | Prednisolone Predsol | Retention enema 20mg/100ml; Suppositories 5mg |
| 06.03.02 | Prednisolone | Tablets 1mg, 5mg |
| 11.04.01 | Prednisolone | Eye drops 0.5% Eye drops 1% (Predforte) |
| 11.04.01 | Prednisolone Minims® Prednisolone Sodium Phosphate | Eye drops 0.5% |
| 24.01 | Prednisolone |
|
| 04.07.03 | Pregabalin | Also approved as an unlicensed indication pre-operatively as part of the gynae enhanced recovery protocol. |
| 04.08.01 | Pregabalin | |
| 15.02 | Prilocaine 2% injection Prilotekal® | Approved by HaRD Area Prescribing Committee September 2013: For subarachnoid block in adult day surgery cases where procedures last under 1 hour |
| 15.02 | Prilocaine Hydrochloride Citanest® | |
| 15.02 | Prilocaine Hydrochloride with Felypressin Citanest with Octapressin® | |
| 03.05.02 | Proactant Alfa Curosurf® | Injection 120mg, 240mg For use on Special Care Baby Unit only |
| 20.01 | Probiotics VSL #3 Sachets and other brands | •Only approved for adults (pouchitis) •All other indications: BLACK - Not recommended for prescribing within the Harrogate and Rural District CCG. |
| 04.06 | Prochlorperazine | Tablets 5mg Liquid 5mg/5ml Injection 12.5mg/ml |
| 04.06 | Prochlorperazine Buccastem® (Buccal preparation) | |
| 04.09.02 | Procyclidine Hydrochloride | Tablets 5mg Liquid 5mg/5ml Injection 10mg/2ml |
| 04.06 | Promethazine Hydrochloride | Tablets 25mg Liquid 5mg/5ml Injection 25mg/ml |
| 13.12 | Propantheline Pro-Banthine ® | |
| 15.01.01 | Propofol | |
| 24.01 | Propranolol |
|
| 24.01 | Propranolol (haemangioma) |
Unlicensed indication |
| 02.04 | Propranolol Hydrochloride Inderal® LA | MR Capsules 160mg |
| 02.04 | Propranolol Hydrochloride Half-Inderal® LA | MR Capsules 80mg |
| 02.04 | Propranolol Hydrochloride | |
| 06.02.02 | Propylthiouracil | |
| 16.01 | ProSource Plus | Approved by the HaRD Area Prescribing Committee, March 2015 |
| 02.08.03 | Protamine Sulphate | Injection 10mg/ml |
| 24.16 | Proxymetacaine 0.5% eye drops Neonatal |
|
| 11.07 | Proxymetacaine Hydrochloride 0.5% with Fluorescein Sodium 0.25% Minims® | |
| 01.06.07 | Prucalopride Resolor | Tablets 1mg |
| 03.10 | Psudoephedrine Hydrochloride Gulpseud® | |
| 03.10 | Psudoephedrine Hydrochloride Sudafed® | Tablets 60mg Liquid 30mg/5ml |
| 05.01.09 | Pyrazinamide | |
| 10.02.01 | Pyridostigmine Bromide Mestinon® | Tablets 60mg |
| 09.06.02 | Pyridoxine Hydrochloride Pyridoxine | Tablets 50mg |
| 04.02.01 | Quetiapine Seroquel® | Tablets 25mg, 100mg, 200mg, 300mg |
| 06.07.01 | Quinagolide Norprolac® | Tablets 25 & 50micrograms (in starter pack), Tablets 75micrograms Initiation on the advice of a specialist |
| 10.02.02 | Quinine sulphate | Tablets 200mg |
| 06.04.01.01 | Raloxifene Hydrochloride Evista® | |
| 02.05.05.01 | Ramipril | Capsules 2.5mg 5mg 10mg |
| 11.08.02 | Ranibizumab Lucentis® | Intravitreal injection 10mg/ml Initiation by Consultant Ophthalmologist only |
| 01.03.01 | Ranitidine | Tablets 150mg, 300mg; Liquid 75mg/5ml |
| 24.01 | Ranitidine |
APC April 2018 -Effervescent ranitidine tablets should be used in patients under 6 years old instead of liquid due to the alcohol content of the liquid being contraindicated for this group. |
| 24.16 | Ranitidine Neonatal |
APC April 2018- Effervescent ranitidine tablets should be used in patients under 6 years old instead of liquid due to the alcohol content of the liquid being contraindicated for this group. |
| 01.03.01 | Ranitidine IV | Injection 50mg/2ml |
| 02.06.03 | Ranolazine Ranexa® |
See NICE CG126: stable angina
|
| 04.09.01 | Rasagiline Azilect® | Tablets 1mg Initiation on the advice of a specialist |
| 04.03.04 | Reboxetine Edronex® | Tablets 4mg |
| 05.03 | Remdesivir |
For the treatment of COVID-19 via Early Access to Medicines Scheme.
|
| 15.01.04.03 | Remifentanil Ultiva® | |
| 03.04.02 | Reslizumab Cinqaero | For use by Respiratory Consultants Only For severe eosinophilic asthma |
| 04.08.01 | Retigabine Trobolt® | Tablets 50mg, 100mg Initiation on the advice of a specialist only. Used as add on treatment in patients with focal onset seizures, which have not been controlled with all other licensed anti-epileptic drug. Comprehensive eye examination required prior to initiation and then repeated every 6 months. |
| 05.01.09 | Rifampicin | Capsules 150mg, 300mg Liquid 100mg/5ml Infusion 600mg |
| 05.01.09 | Rifampicin and Isoniazid Rifinah® 150 and 300 | |
| 05.01.09 | Rifampicin and Isoniazid and Pyrazinamide Rifater® | |
| 05.01.07 | Rifaximin 550mg tablets Targaxan® | Approved by the Area Prescribing Committee, May 2015, in line with NICE TA337 |
| 04.09.03 | Riluzole Rilutek® | Tablets 50mg Initiation on the advice of a specialist |
| 11.04.01 | Rimexolone Vexol® | Eye drops 1% |
| 04.05.02 | Rimonabant Acomplia® | Not stocked at HDFT Initiation on the advice of a specialist |
| 13.05.03 | Risankizumab Skyrizi® | |
| 06.06.02 | Risedronate Sodium Actonel® | Tablets 35mg Tablets 30mg (for Pagets disease only) |
| 04.02.01 | Risperidone Risperdal® | Tablets 500 micrograms, 1mg, 3mg Liquid 1mg/ml |
| 04.02.02 | Risperidone Risperdal Consta® | Injection 25mg, 37.5mg, 50mg |
| 07.01.03 | Ritodrine Hydrochloride Yutopar® | Tablets 10mg |
| 08.02.03 | Rituximab Truxima® | |
| 10.01.03 | Rituximab Truxima® | Initiation on the advice of a specialist |
| 02.08.02 | Rivaroxaban Xarelto® | As per NICE guidelines |
| 04.11 | Rivastigmine | Capsules 1.5mg Patches 4.6mg Initiation on the advice of a specialist. Patches ONLY for patients unable to take capsules. |
| 20 | ROBINUL-NEOSTIGMINE inj (1ml) | |
| 15.01.05 | Rocuronium Bromide Esmeron® | |
| 03.03.03 | Roflumilast Daxas | 500mcg tablets Not currently prescribed at HDH |
| 04.09.01 | Ropinirole | Tablets 250micrograms, 1mg Initiation on the advice of a specialist |
| 04.09.01 | Ropinirole MR (XL) Ipnnia XL® | 2mg, 3mg, 4mg, 6mg and 8mg tablets |
| 02.12 | Rosuvastatin Crestor® | Tablets 5mg, 10mg, 20mg For use by Consultant Cardiologists only |
| 14.04 | Rotavirus vaccine Rotarix® | |
| 24.16 | Rotavirus vaccine (Rotarix) Neonatal |
|
| 04.09.01 | Rotigotine Neupro® | Patches 2mg, 4mg, 6mg, 8mg Initiation on the advice of a specialist |
| 02.05.05.02 | Sacubitril/valsartan Entresto® | To be prescribed in line with NICE TA388 |
| 04.09.01 | Safinamide Xadago® | 50mg and 100mg film coated tablets Approved by the HaRD Area Prescribing Committee December 2016 |
| 03.01.01.01 | Salbutamol | Inhaler 100micrograms/dose Easyhaler 100micrograms/dose Nebules 2.5mg/2.5ml, 5mg/2.5ml MR tablets 4mg Liquid 2mg/5ml Injection 500micrograms/ml (hospital only) |
| 07.01.03 | Salbutamol | Nebules 5mg |
| 24.01 | Salbutamol |
|
| 24.16 | Salbutamol Neonatal |
|
| 13.07 | Salicylic Acid Occlusal® | |
| 13.05.02 | Salicylic Acid 2% w/w, Sulphur 2% w/w in Aqueous Cream | |
| 13.06.01 | Salicylic Acid 3% w/w, Sulphur 3% w/w in Aqueous Cream | |
| 13.05.02 | Salicylic Acid in White Soft Paraffin | |
| 13.06.01 | Salicylic Acid in White Soft Paraffin | |
| 03.01.01.01 | Salmeterol Serevent® | |
| 10.01.03 | Sarilumab | |
| 01.07.02 | Scheriproct | Ointment |
| 20.01 | Secukinumab Cosentyx® | Approved in line with NICE TA350 |
| 04.09.01 | Selegiline Hydrochloride | Tablets 5mg Liquid 10mg/5ml |
| 06.01.02.03 | Semaglutide pre filled pen Ozempic | 0.25mg, 0.5mg, 1mg |
| 01.06.02 | Senna | Tablets 7.5mg; Liquid 7.5mg/5ml |
| 04.03.03 | Sertraline | Tablets 50mg, 100mg |
| 09.05.02.02 | Sevelamer Renagel® | Tablets 800mg Initiation on the advice of a Renal Specialist |
| 15.01.02 | Sevoflurane | |
| 13.09 | Shampoos Capasal® | |
| 04.05.02 | Sibutramine Hydrochloride Reductil® | Capsules 10mg Initiation on the advice of a specialist |
| 07.04.05 | Sildenafil | Generic sildenafil is no longer listed on the SLS criteria set out in the drug tariff. |
| 13.07 | Silver Nitrate | |
| 24.01 | Similac Alimentum | Paediatric Nutritional Products List - approved APC 05/18 |
| 03.09.02 | Simple Linctus, BP | |
| 02.12 | Simvastatin | Tablets 20mg, 40mg |
| 08.02.02 | Sirolimus Rapamune® | |
| 06.01.02.03 | Sitagliptin Januvia® | Tablets 100mg Initiation on the advice of a specialist |
| 24.01 | Sodium benzoate |
Unlicensed |
| 09.02.01.03 | Sodium Bicarbonate | Capsules 500mg |
| 09.02.02.01 | Sodium Bicarbonate Min-I-Jet® Sodium Bicarbonate | Minijet 4.2%, 8.4% |
| 12.01.03 | Sodium Bicarbonate | Ear drops 5% |
| 24.16 | Sodium bicarbonate Neonatal |
|
| 09.02.02.01 | Sodium Bicarbonate Infusion | Polyfusor 1.26% (500ml) 2.74% (500ml) 4.2% (500ml) 8.4% (200ml) |
| 03.01.05 | Sodium Chloride | Sodium chloride 0.9% 5ml, 10ml |
| 24.16 | Sodium chloride Neonatal |
|
| 13.11.01 | Sodium Chloride 0.9% | |
| 09.02.02.01 | Sodium chloride 3% solution Hypertonic saline | |
| 09.02.02.01 | Sodium Chloride and Glucose Intravenous Infusion | NaCl 0.9%, Glucose 5% (500ml) NaCl 0.45%, Glucose 5% (500ml) NaCl 0.18%, Glucose 4% (500ml) NaCl 0.18%, Glucose 4% (1000ml) NaCl 0.18%, Glucose 10% (500ml) |
| 09.02.02.01 | Sodium Chloride Intravenous | 0.45% (500ml) 0.9% (50ml & 50ml Minibag plus) 0.9% (100ml & 100ml Minibag plus) 0.9% (250ml) 0.9% (500ml) 0.9% (1000ml) 5% Polyfusor (500ml) |
| 07.04.04 | Sodium Citrate | Solution for bladder irrigation 30ml |
| 01.06.04 | Sodium Citrate (Rectal) Micralax® Micr-enema | |
| 11.04.02 | Sodium Cromoglicate | Eye drops 2% |
| 09.01.01.01 | Sodium Feredetate Sytron® | Liquid 27.5mg iron in 5ml |
| 05.01.07 | Sodium fusidate | Tablets 250mg Liquid 250mg/5ml (Dose of 750mg TDS equivalent to 500mg TDS for tablets) Infusion 500mg powder with diluent |
| 11.08.01 | Sodium hyaluronate 0.2% Evolve HA® | |
| 13.11.04 | Sodium Hypochorite Solution 1% Milton® | |
| 09.02.02.01 | Sodium Lactate Intravenous Infusion, Compound | 500ml, 1000ml |
| 24.16 | Sodium Phosphate Neonatal |
Joulies phosphate solution (unlicensed medicine) |
| 01.06.02 | Sodium Picosulfate | Elixir 5mg/5ml |
| 24.01 | Sodium picosulfate |
|
| 04.08.01 | Sodium Valproate | Crushable tablets 100mg EC tablets 200mg, 500mg MR tablets 300mg, 500mg Liquid 200mg/5ml Injection 300mg/3ml |
| 24.01 | Sodium valproate |
|
| 09.02.01.01 | Sodium Zirconium Cyclosilicate | NOTE** For Renal patients: This medicine is restricted - Named patient basis only APC December 2019
|
| 07.04.02 | Solifenacin Succinate Vesicare® | Tablets 5mg, 10mg |
| 02.04 | Sotalol Hydrochloride | Tablets 40mg, 80mg |
| 02.02.03 | Spironolactone | |
| 24.16 | Spironolactone Neonatal |
|
| 03.01.05 | Standard range peak flow meter MicroPeak® | |
| 13.11.07 | Sterile Larvae (Maggots) LarvE® | |
| 12.03.03 | Strepsils lozenges | Original |
| 02.10.02 | Streptokinase | Injection 1.5million units Intrapleural use for empyema |
| 01.03.03 | Sucralfate Antepsin® | Unlicensed preparation approved for use by the gastroenterology consultants only. Approved as a Red Drug until the licensed preparation is available again. |
| 20 | Sucralfate 2g/50ml enema | Management of chronic radiation proctitis. |
| 20 | Sucrose 24% Sweet-Ease® | For procedural pain relief in neonates |
| 01.05.01 | Sulfasalazine | Tablets plain/ e/c 500mg (note plain tablets are cheaper than e/c in primary care) |
| 10.01.03 | Sulfasalazine | Tablets EC 500mg |
| 04.02.01 | Sulpiride | Tablets 200mg; Liquid 200mg/5ml |
| 04.07.04.01 | Sumatriptan | Tablets 50mg |
| 24.01 | Sumatriptan |
|
| 24.16 | Suxamethonium Neonatal |
|
| 15.01.05 | Suxamethonium Chloride | |
| 24.16 | Syrup BP Neonatal |
Unlicensed For cannulation |
| 24.16 | Sytron (Sodium feredetate) Neonatal |
For all breast milk fed babies, particularly if: 1. Weight <1500g 2. <34 weeks gestation 3. IUGR Consider iron supplementation in mixed fed infants if they are fed more breast milk than formula. Commence at 28 days of age. Continue up to 6-12 months of age depending on diet. Dose: 1ml per day or 0.5ml per day if mixed fed. Note: ESPGHAN recommends a dose of 2-3mg/kg/day. Iron supplementation may be started at 2-6 weeks of postnatal age. Anaemia of prematurity is not iron deficiency. |
| 08.02.02 | Tacrolimus Adoport® | Prescribe by brand |
| 08.02.02 | Tacrolimus Prograf® | Capsules 500micrograms, 1mg Prescribe by brand due to interpatient variability |
| 08.02.02 | Tacrolimus Advagraf® | Capsules 500micrograms, 1mg Prescribe by brand For use by Renal Unit only |
| 13.05.03 | Tacrolimus Protopic® | |
| 07.04.05 | Tadalafil Generic | PRN use formulary second line to generic sildenafil thst fulfil the SLS criteria Daily use non-formulary. |
| 20 | TALC BP purified sterile 4g,10g | |
| 08.03.04.01 | Tamoxifen | Tablets 10mg, 20mg |
| 07.04.01 | Tamsulosin Hydrochloride | Capsules 400micrograms |
| 13.05.02 | Tars Coal Tar Paster BP | |
| 13.05.02 | Tars Cocois® | |
| 13.05.02 | Tazarotene 0.05% Zorac® | |
| 05.01.07 | Teicoplanin Targocid® | Injection 200mg & 400mg powder |
| 04.01.01 | Temazepam | Tablets 10mg, 20mg Liquid 10mg/5ml |
| 05.01.01.02 | Temocillin Negaban® | Microbiology advice only |
| 02.10.02 | Tenecteplase Metalyse® | Injection 8000units, 10000units Use in accordance with thrombolysis protocol. |
| 24.01 | Tentrini | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Tentrini Energy | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Tentrini Energy Multifibre | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Tentrini Multifibre | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Tentrini Multifibre | Paediatric Nutritional Products List - approved APC 05/18 |
| 24.01 | Tentrini Multifibre | Approved by APC 05/18 for use by prescribers following: GUIDELINES FOR THE IN-PATIENT MANAGEMENT OF PAEDIATRIC PATIENTS WITH EATING DISORDERS (UNDER 16 YEARS) see link. Also on Paediatric Nutritional Products list - approved APC 05/18 see link |
| 13.10.02 | Terbinafine Hydrochloride 1% Lamisil® | |
| 03.01.01.01 | Terbutaline Sulphate Bricanyl® | Turbohaler 500micrograms/dose Liquid 1.5mg/5ml |
| 07.01.03 | Terbutaline Sulphate | Injection 500micrograms/ml |
| 06.06.01 | Teriparatide Terrosa | Pre-filled pen 250 micrograms/ml |
| 06.05.02 | Terlipressin Variquel® | Injection 1mg |
| 06.01.06 | Test Strips Multistix 8SG® | |
| 06.01.06 | Test strips Contour | |
| 06.01.06 | Test Strips Freestyle optium | |
| 06.01.06 | Test strips Freestyle optium beta-ketone | |
| 06.01.06 | Test strips Gluco Rx HCT | |
| 06.01.06 | Test strips Gluco Rx Ketone | |
| 06.01.06 | Test strips GlucoMen LX sensor | |
| 06.01.06 | Test strips GlucoRx Nexus test strips | |
| 06.01.06 | Test Strips: GluNeo test strips | |
| 24.01 | Testosterone Restandol® 40mg Testocaps | By specialist recommendation only. All monitoring is done by hospital specialist prescriber along with dose changes if appropriate during the 4 month treatment. The specialist will write to the GP with a standard clinic letter as appropriate. June 2018 APC. |
| 06.04.02 | Testosterone and Esters Sustanon 250® | Injection 1ml (oily) - Testosterone propionate 30mg, testosterone phenylpropionate 60mg, testosterone isocaproate 60mg, testosterone decanoate Initiation on the advice of a specialist |
| 06.04.02 | Testosterone and Esters Testosterone (implant) | Implant 200mg Initiation on the advice of a specialist |
| 06.04.02 | Testosterone and Esters Testogel® | Gel sachets 50mg Initiation on the advice of a specialist |
| 14.05.02 | Tetanus immunoglobulin | |
| 15.02 | Tetracaine (Amethocaine) Ametop® | |
| 24.16 | Tetracaine (Ametop®) Neonatal |
|
| 11.07 | Tetracaine Hydrochloride Minims® Amethocaine Hydrochloride | Eye drops 1% |
| 06.05.01 | Tetracosactide Synacthen® | Injection 250micrograms/ml |
| 24.01 | Tetracosactide (Synacthen) |
|
| 09.02.02.02 | Tetrastarch Volulyte® | 6% (500ml) |
| 08.02.04 | Thalidomide Pharmion® | Capsules 50mg Patient authorisation form must be sent with each prescription |
| 03.01.03 | Theophylline | See under individual brand names Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin. |
| 03.01.03 | Theophylline Nuelin® SA | MR tablets 175mg, 250mg Prescribe by brand. Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin. |
| 03.01.03 | Theophylline Slo-Phyllin® | MR capsules 60mg, 125mg Prescribe by brand. Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin. |
| 03.01.03 | Theophylline Uniphyllin® Continus | MR tablets 200mg, 300mg, 400mg Prescribe by brand. Monitor theophylline plasma levels when prescribed concomitantly with calcium channel blockers, cometidine, ciprofloxacin, clarithromycin or erythromycin. |
| 09.06.02 | Thiamine | Tablets 50mg, 100mg |
| 09.06.02 | Thiamine Pabrinex® | IM injection IV injection |
| 24.16 | Thick and Easy Neonatal |
|
| 15.01.01 | Thiopental Sodium | |
| 04.08.01 | Tiagabine Gabitril® | Not stocked at HDFT Initiation on the advice of a Neurologist |
| 12.02.01 | Tiamcinolone Acetonide Nasacort® | Aqueous nasal spray 55micrograms/metered spray |
| 02.09 | Ticagrelor Brilique® | 60mg tablets 90mg tablets |
| 05.01.03 | Tigecycline Tygacil® | Injection 50mg powder For use on microbiology advice ONLY |
| 24.01 | Timolol 0.5% long acting eye drops (topical treatment of haemangioma) |
Unlicensed indication of a licensed drug |
| 11.06 | Timolol Maleate | Eye drops 0.25%, 0.5% |
| 11.06 | Timolol Maleate Once-daily Timoptol®-LA | Infantile haemangioma |
| 24.01 | Tinzaparin |
|
| 02.08.01 | Tinzaparin Sodium | |
| 03.01.02 | Tiotropium Spiriva® | Respimat® 2.5mcg/dose Handihaler® 18mcg/dose |
| 03.01.04 | Tiotropium / olodaterol Respimat Spiolto Respimat | Licnensed for COPD only |
| 02.09 | Tirofiban Aggrastat® | |
| 10.02.02 | Tizanidine | Tablets 2mg Initiation on the advice of a specialist |
| 05.01.04 | Tobramycin (Bramitob) | 75mg/ml Nebuliser solution |
| 05.01.04 | Tobramycin Podhaler Tobi® | |
| 10.01.03 | Tocilizumab RoActemra® | |
| 10.01.03 | Tocilizumab RoActemra® | Approved by the HaRD Area Prescribing Committee, January 2015 |
| 10.01.03 | Tofacitinib Xeljanz | For initiation by Consultant Rheumatologists and Gastroenterologists
|
| 07.04.02 | Tolterodine Tartrate Detrusitol® | |
| 07.04.02 | Tolterodine Tartrate modified release Detrusitol® XL |
|
| 06.05.02 | Tolvaptan Samsca® | Patients requiring tolvaptan are managed by York Teaching Hospitals |
| 04.08.01 | Topiramate Topamax® | |
| 24.01 | Topiramate (migraine) |
|
| 04.07.02 | Tramadol Hydrochloride | Capsules 50mg Injection 100mg/2ml MR tablets - restricted to patients non-compliant with regular tramadol |
| 02.11 | Tranexamic Acid | Tablets 500mg; Injection 500mg/5ml |
| 24.01 | Tranexamic acid |
|
| 08.01.05 | Trastuzumab Herceptin® | |
| 08.01.05 | Trastuzumab emtansine Kadcyla® | Approved in February 2014 as per Cancer Drugs Fund (CDF)guidelines |
| 11.06 | Travoprost Travatan® | For when patients have poor response to latanoprost |
| 11.06 | Travoprost with Timolol DuoTrav® | |
| 04.03.01 | Trazodone Hydrochloride | Capsules 50mg, 100mg Liquid 50mg/5ml |
| 08.01.05 | Tretinoin | One box stored in Pharmacy EMCU. Out of Hours; please contact the on-call pharmacist |
| 10.01.02.02 | Triamcinolone Acetonide Kenalog® | |
| 20.01 | TRIAMCINOLONE HEXACETONIDE 20mg/ml inj | Consultant Rheumatology Use Only
|
| 20 | TRICHLORACETIC ACID 90% SOLUTION | Approved by HaRD Area Prescribing Committee January 2014 for Consultant Dermatologists use only. |
| 04.02.01 | Trifluoperazine | Tablets 1mg, 5mg Liquid 5mg/5ml |
| 08.01.05 | Trifluridine / Tipiracil Lonsurf® | NICE TA405: Trifluridine–tipiracil for previously treated metastatic colorectal cancer |
| 04.09.02 | Trihexyphenidyl Hydrochloride | Tablets 2mg, 5mg Liquid 5mg/5ml (previously known as benzhexol) |
| 02.06 | Trimetazidine Unlicensed | MR Tablets 35mg For use by specialists as last line therapy for unstable angina |
| 05.01.13 | Trimethoprim | Tablets 100mg, 200mg Liquid 50mg/5ml |
| 24.01 | Trimethoprim |
|
| 24.16 | Trimethoprim Neonatal |
|
| 08.03.04.02 | Triptorelin Gonapeptyl Depot® | Injection 3.75mg Paediatric use only for precocious puberty |
| 11.05 | Tropicamide Mydriacyl® | Eye drops 0.5% |
| 11.05 | Tropicamide single use Minims® Tropicamide | Eye drops 0.5%, 1% |
| 07.04.02 | Trospium Chloride Regurin® | |
| 07.04.02 | Trospium Chloride Regurin® XL | |
| 20 | TUBERCULIN PPD 2TU Injection 20 units in 1 mL | |
| 24.01 | Tuberculosis medicines |
|
| 07.03.05 | Ulipristal Acetate EllaOne® | Tablet Ulipristal acetate 30mg To be used 72-120hourse after unprotected sexual intercourse |
| 03.01.02 | Umeclidinium Incruse® Ellipta | Licensed for COPD only. |
| 03.01.04 | Umeclidinium / vilanterol Anoro Ellipta® | Licensed for COPD only |
| 02.08.01 | Unfractionated Heparin | Sub-cutaneous injection 5000 units/0.2ml - for VTE prophylaxis if CrCl <10ml/min. Injection 1000units/ml (20ml ampoules) - for use as an infusion (see individual charts). Injection 50 units/5ml - For central lines and paediatric peripheral lines only. Heparinised saline 1000 units/500ml For use in cardiac unit only. |
| 01.07.02 | Uniroid HC | For Primary Care prescribing only; product not stocked at HDH |
| 13.02.01 | Urea 40% Special Preparation | 50g Not kept as stock in pharmacy |
| 07.04.04 | Urinary Catheter Balloon containing Triclosan Farcofill® | For patients who require catheter changes more than once every 4 weeks or who require maintenance solutions more than once every 2 weeks. This was approved by the APC for 4 patients per District Nursing Team (North, South, East and West). |
| 02.10.02 | Urokinase Syner-KINASE® | Injection 25000 units For thrombosed intravascular catheters and cannulae & peripheral vascular occlusion |
| 24.01 | Urokinase |
|
| 01.09.01 | Ursodeoxycholic acid Ursogal® | Tablets 150mg |
| 01.09.01 | Ursodeoxycholic acid Ursofalk® | Capsules 250mg; Suspension 250mg/5ml |
| 13.05.03 | Ustekinumab Stelara® | |
| 24.16 | Vaccines - primary immunisation course Neonatal |
|
| 05.03.02.02 | Valganciclovir Valcyte® | |
| 04.02.03 | Valproic Acid Depakote® | Tablets 250mg |
| 02.05.05 | Valsartan Diovan® | Tablets 40mg; Capsules 80mg, 160mg For heart failure post myocardial infarction only |
| 24.01 | Vamcomycin |
|
| 05.01.07 | Vancomycin | Injection 500mg & 1g powder (hospital only) Capsules 125mg |
| 24.16 | Vancomycin Neonatal |
|
| 04.10 | Varenicline Champix® | Tablets 500micrograms, 1mg |
| 14.05.02 | Varicella-Zoster immunoglobulin | |
| 06.05.02 | Vasopressin Pitressin® | Injection 20units/ml |
| 01.05.03 | Vedolizumab Entyvio® | Approved in line with NICE TA342 and NICE TA352 |
| 08.01 | Venetoclax Venclyxto® | |
| 04.03.04 | Venlafaxine Efexor® | Tablets 37.5mg, 75mg (Twice daily dosing) Doses above 300mg on the advice of a specialist (AMBER-shared care) |
| 04.03.04 | Venlafaxine Efexor® XL | Capsules 75mg, 150mg To be initiated only in patients non-compliant with twice daily dosing. Doses above 300mg on the advice of a specialist |
| 02.06.02 | Verapamil Hydrochloride | Tablets 40mg, 80mg, 120mg; Injection 5mg/2ml (hospital only) |
| 11.08.02 | Verteporfin Visudyne® | Injection 15mg |
| 04.08.01 | Vigabatrin Sabril® | Tablets 500mg Sachets 500mg Initiation on the advice of a Neurologist |
| 08.01.04 | Vinblastine Sulphate | |
| 08.01.04 | Vincristine Sulphate | |
| 08.01.04 | Vinorelbine | |
| 09.06.07 | Vitamin and mineral suppliments Forceval® | Capsules and soluble tablets Approved July 2018 APC meeting for Refeeding protocol - see link |
| 09.06.02 | Vitamin B complex preparations Vigranon B® | Long-term manufacturing problem |
| 09.06.02 | Vitamin B Tablets (Compound Strong) | Contain nicotinamide 20mg, pyridoxine 2mg, riboflavin 2mg, thiamine 5mg |
| 20 | Vitamin D - Colecalciferol 25micrograms (1000units) | Licensed as a dietary supplement |
| 24.16 | Vitamin K (phytomenadione) Neonatal |
|
| 10.03.02 | Voltarol Emulgel® | |
| 05.02.01 | Voriconazole | On the advice of a specialist |
| 24.01 | Warfarin |
|
| 02.08.02 | Warfarin Sodium | |
| 09.02.02.01 | Water for Injection | 5ml, 10ml, 20ml, 100ml |
| 13.02.01 | White Soft Paraffin BP | 500g |
| 02.02.01 | Xipamide Diurexan® | |
| 12.02.02 | Xylometazoline Hydrochloride Otrivine® | Nasal drops 0.1% Paediatric nasal drops 0.05% |
| 13.02.01 | Yellow Soft Parrafin BP | 15g |
| 13.02.01 | Zerodouble gel | |
| 13.02.01 | Zeroguent cream | |
| 13.02.01 | Zeroveen® | Not stocked at HDH |
| 24.16 | Zidovudine Neonatal |
|
| 20 | ZINC & SALICYLIC ACID PASTE BP (lassars paste) 60g | |
| 13.02.02 | Zinc and Caster Oil Ointment BP | 15g |
| 09.05.04 | Zinc Sulphate | Effervescent tablets 125mg(45mg elemental zinc) |
| 06.06.02 | Zolendronic Acid Aclasta® | Injection 4mg Injection 5mg Initiation on the advice of a specialist |
| 04.08.01 | Zonisamide Zonegran® | Capsules 25mg, 50mg, 100mg Initiation on the advice of a Neurologist |
| 04.01.01 | Zopiclone | Tablets 3.75mg, 7.5mg First choice hypnotic in primary care |
| 04.02.01 | Zuclopenthixol Acetate Clopixol Acuphase® | Injection 50mg/ml |
| 04.02.02 | Zuclopenthixol Decanoate Clopixol® | Injection 200mg/ml, 500mg/ml |
| 04.02.01 | Zuclopenthixol Dihydrochloride Clopixol® | Tablets 2mg, 10mg, 25mg |